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Memories shape our lives. 
Memories remind us of our successes and our failures,  
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1.1 Introduction 
The vertebrate body is a remarkable collection of different tissues and cell-types 
with unique functions, shapes and sizes. The diversity of cells is the result of precise 
regulation of gene expression during development and cell differentiation of stem 
cells towards their final mature state.  
Stem cells are unspecialized cells that are the source of all tissues and organs that we 
possess during our life. The best-known stem cells are embryonic stem cells that are 
capable of forming all the different cell types of our body. During our life, 
specialized cells will often need to be replaced due to normal turnover or injury. To 
be able to replace the lost cells, our body possesses pools of tissue-specific stem 
cells and lineage committed progenitors. An organized balance between stem cells 
and mature cell populations is crucial for the long-term maintenance of functional 
tissue types. Stem cells maintain this balance via fine-tuned regulation of processes 
like self-renewal, proliferation, differentiation and apoptosis. This means that genes 
that are responsible for these processes need to be turned on and off, either in a 
programmed fashion or in response to the environment of the cell. If the regulation 
of gene expression is disturbed this can potentially lead to tissue malformation or 
disease.  
 
 
1.2 Stem Cells 
Stem cells are defined as cells that are clonogenic, self-renewing, and unspecialized 
with the capacity to differentiate into multiple cell lineages. The ability to self-renew 
is arguably the most important characteristic of a stem cell as it allows for extended 
production of differentiated cells throughout the life span of the animal. Multipotent 
cells with (limited) clonogenic behavior, but lacking self-renewal are termed 
progenitor cells. However, for a number of populations that have been termed stem 
cells, the criterion of self-renewal has not been determined. Because progenitor cells 
may closely resemble stem cells in terms of their properties, and because stem cells 
are not always readily testable for the above-mentioned criteria, some confusion will 
likely continue to exist (33,133,203,283). 
  
Stem cells are not very easy to define, but based on their known abilities to 
differentiate into a particular set of cell types, they can roughly be classified in three 
groups. The first group is called totipotent or omnipotent and is represented by the 
zygote that can give rise to the complete embryo as well as the trophoblast. 
However, even this most primitive stem cell does not actually meet the stem cell 
criteria as they are poorly clonogenic and have a very limited self-renewal capacity 
(305). A little later in embryonic development, a second group of stem cells emerges 
that are called pluripotent stem cells. These cells can, similar to the zygote, 
differentiate towards cells of all three germ layers (endoderm, mesoderm, and 
ectoderm), but not to the trophoblast. The best studied pool of pluripotent cells are 
the embryonic stem cells, which can be derived from the inner cell mass of the 
blastocyst (272). The last group contains the multipotent cells, which are capable of 
differentiation within a single germ layer. These cells are also called tissue stem 
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cells, or adult stem cells, as they may be responsible for maintaining tissue 
homeostasis by replacing cells that are lost through normal turnover or injury (183). 
Tissue-specific stem cells have been described for many organs that have the 
capability to regenerate or repair. One well-characterized tissue stem cell type, 
which has been shown to meet the stem cell critera mentioned above is the 
hematopoietic stem cell. Hematopoietic stem cells (HSC) mainly reside in the bone 
marrow and are responsible for the supply off all the different blood cell lineages 
that are produced during our life (80,225). While studying hematopoiesis, 
Friedenstein and coworkers discovered that the bone marrow might contain at least 
two types of stem cells. It does not just contain the hematopoietic stem cells, but 
also contains precursors with osteogenic potential (99,239). This osteogenic 
precursor is a component of the bone marrow stroma. This is a supportive tissue of 
major importance for the formation of the hematopoietic microenvironment, in 
which the hematopoietic stem cells reside, proliferate and differentiate (203,307). 
Soon after the initial finding of the osteogenic precursors it became clear that these 
cells were able to differentiate towards a whole set of different mesenchymal tissues. 
These cells are usually described as stromal stem cells or mesenchymal stem cells 
(MSC).  
 
 
1.3 Mesenchymal Stem Cells 
1.3.1 Definition 
MSC are defined as multipotent cells with mesenchymal differentiation potential 
towards for example cartilage, bone, fat, smooth muscle, hematopoietic supportive 
stroma, pericytes and tendon (69,241,288). Like for many other tissue stem cells, it 
is unclear whether cultured MSC should actually be regarded as stem cells or as 
early committed cells that have been derived from a more primitive stem cell pool 
(133). The arguments against the term stem cells for cultured MSC are based on the 
observation that only a fraction of MSC in culture retain a clonogenic potential (91). 
Also, they have not been properly assayed in vivo for properties like self-renewal 
and capacity for multilineage reconstitution, although they have been shown to 
contribute to bone repair upon transplantation (18). One major problem is that is it is 
unknown how MSC expanded in culture reflect the in vivo situation. To date, no 
specifically defined cell markers have been described that would allow direct 
identification of MSC in a tissue (see also below; CFU-F assays). However, taken 
the fact that mesenchymal tissues are subject to replacement and repair during the 
entire life of an organism, it is generally accepted that MSC exist in vivo but just 
lack a precise definition that would allow their isolation and comparison to their 
cultured derivatives (19,241). 
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1.3.2 Clinical applications 
Because of their ability to differentiate towards several mesenchymal cell types 
MSC are interesting for tissue engineering, and many studies have been dedicated to 
the development of therapeutic (orthopaedic) strategies (81). MSC were also 
reported to undergo trans-differentiation towards multiple non-mesenchymal cell 
types (9), for example neurons (164), hepatocytes (173) and cardiac muscle (125) 
either upon addition of specific stimuli in vitro, or via induced injuries in vivo. 
However, some of the trans-differentiation results are somewhat controversial and 
could be caused by cell fusion and poor histological characterisation (6,43,126,187) 
or might actually involve different types of tissue stem cells that were co-purified 
from the bone marrow (167,168). Another interesting characteristic of MSC is that 
these cells possess immunosuppressive properties, making them a very interesting 
tool for therapeutic bone marrow transplantation and targeted gene-therapy 
(17,19,351). The use of MSC in therapeutic strategies is summarized in a large 
number of reviews, e.g (19,21,28,210,251,254,354). 
 
 
1.3.3 The CFU-F assay 
The main reason that MSC have not been identified in vivo is the lack of definition 
of a unique set of membrane epitopes or gene products that can be tagged. Several 
investigators have reported combinations of cell surface proteins that should be 
absent or present on MSC (19,74,149,210,270).However, these are often too 
commonly expressed on a range of mesenchymal cell types to be useful for sorting 
MSC. The identification of MSC has therefore relied primarily on in vitro assays. A 
commonly used assay to study MSC is the colony forming unit-fibroblast (CFU-F) 
assay (92). This assay has been established for a wide range of mammalian species 
and is based on the ability of MSC to form plastic or glass adherent colonies, each 
from a single precursor. The cells in the colonies have a fibroblast-like morphology 
(see Figure 1) and can be expanded in vitro while maintaining the capacity to 
differentiate into mesenchymal cell types. Although CFU-F cultures are usually 
composed of a heterogeneous cell population, this assay has been used as an in vitro 
correlate for MSC potential and most of the current knowledge of MSC is based on 
analysis of these culture-expanded cells.  
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1.3.4 Tissue-specific properties.  
In addition to bone marrow, MSC have been isolated via CFU-F cultures from 
nearly every adult tissue from adult mammals as well as from several tissues during 
embryonic development (65,95,136,206,264,273,324). Although the cells derived 
from different locations are often considered to be similar, they actually show 
marked phenotypic differences that are in part correlated to the tissue that they 
reside in. MSC from different organs have intrinsic differences in their proliferative 
capacity, differentiation potential and ability to support hematopoiesis. These 
differences are maintained during in vitro culture and also upon re-transplantation in 
vivo (65,94,96,98,136,273). This highly cell-autonomous behaviour of MSC again 
suggests that these cultured cells are a commited derivative from a still elusive 
parent. For example, it was shown that MSC from spleen and thymus were not able 
to spontaneously form fibrous tissue and bone when transplanted into the peritoneal 
cavity in a diffusion chamber, in contrast to MSC from bone marrow (93). 
Comparison between CFU-F of five different inbred mouse strains revealed 
enormous variation in MSC yield, the growth kinetics and the levels of alkaline 
phosphatase expression, suggesting a variety in osteogenic potential (244). A culture 
of human MSC suggested that the cells are present at various stages of 
differentiation and with distinct osteogenic potentials. Also, major differences in 
both growth rate and alkaline phosphatase activity between MSC from different 
individuals and even between MSC from different aspirates from the same 
individual were observed (245). Mesenchymal cell lines derived from different 
anatomical locations of the embryo have distinct expression of differentiation 
lineage markers. Human fetal MSC derived from BM, liver, lung and spleen were 
shown to have a comparable morphology and immunophenotype, but are different in 
their differentiation capacity (136). The basis of these differences is unknown and 
several researchers have embarked on doing expression studies on MSC from 
different sources e.g. (48,108,233,289,320,321,330,331,338). This showed clear 
Figure 1. 
A CFU-F colony, approximately 2 mm in 
diameter, from sternum bone marrow 
after 10 days of culture. 
Chapter 1 
14  
 
differences at the transcriptional level between MSC from different tissues. For 
instance, mouse fetal liver cell lines expressed high levels of extracellular matrix 
genes whereas cell lines from the aorta-gonad-mesonephros region (AGM) express 
more vascular smooth muscle genes (48). A serial analysis of gene expression 
(SAGE) of MSC derived from adult human bone marrow and umbilical cord show a 
lot of similarity, but expressed different combinations of differentiation markers 
(233). A gene expression study by Götherström et al (108) compared human fetal 
liver and adult bone marrow MSC. They speculated that fetal MSC have a higher 
proliferative capacity when compared to adult MSC as they express more genes 
involved in cell-cycle regulation, DNA repair and chromatin modification. 
Furthermore, because fetal cells expressed less lineage commitment markers they 
suggest that these cells are more multi potent than the adult cells. 
However the key factors that define the MSC characteristics have yet to be 
identified. More research is needed to answer the question whether the different 
sources of MSC represent the same cell type, and how these are related with respect 
to their embryonic origin. 
 
 
1.3.5 Residence and origin 
It is unclear whether all MSC originate from a common precursor population in the 
embryo and later colonize different organs, or arise locally from organ primordia. 
One possible pool of pluripotent cells from which MSC could be derived during 
adult life, are the MAPC, which stands for the somewhat confusing name 
multipotent adult progenitor cells (145). The isolation of MAPC relies on the same 
sources and the same adherent properties as that of MSC although additional 
purification steps are added to enrich this extremely small population of cells. In 
contrast to MSC, MAPC are not restricted to mesenchymal lineages, but 
differentiate in vitro also into cells of visceral mesoderm, neuroectoderm, and 
endoderm. When injected into an early blastocyst, a single MAPC contributes to 
most, if not all, somatic cells (144). MAPC also seem to meet the criterion of self-
renewal as they proliferate extensively for more than 100 population doublings 
without obvious senescence or loss of differentiation potential (325). However, no 
direct lineal relationship is known between MAPC and MSC and these are therefore 
treated as two independent stem cell populations. Detailed microscopic analysis led 
to the hypothesis that MSC or their derivatives reside in the blood vessel walls as 
multipotent pericytes (288,353). Phenotypical and morphological data from several 
researchers may also indicate that BM MSC are identical to the BM stromal 
supportive cells termed adventitial reticular cells (ARC) (149). Already in 1975 it 
was shown that ARC likely originate from the already preformed cartilage where 
these cells seem to prepare the microenvironment to which the hematopoietic cells 
migrate via newly formed blood vessels (54). It even remains possible that ARC, 
bone lining osteoblasts and pericytes, that all form part of an extended stromal 
marrow network all possess the multipotent capacity and could all be identified as 
MSC (149). 
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Alternatively, MSC might arise in a central location and later colonize different 
organs. During fetal development, CFU-F can be found at sites of active 
hematopoiesis. The appearance of MSC in the hematopoietic sites slightly precedes 
the migration of the HSC from the fetal liver to the bone marrow cavity (324). 
However, these experiments do not actually prove that the MSC colonize the tissues 
via migration.  
 
 
1.3.6 Circulation 
One of the reasons that colonization of MSC in the different tissues is not likely 
caused via migration in the blood stream is that the migratory properties of MSC via 
the circulation are rather poor. Although several researchers have reported the 
isolation of MSC from the adult bloodstream, others contradict this observation 
(172,190,246,326,337). However, it is possible that fetal MSC migrate more 
extensively (38,206). 
Because of the therapeutic interest, several researchers have addressed the 
possibilities of MSC homing to either their original site of isolation or to injured 
tissue. MSC freshly prepared from the bone marrow home to the bone marrow when 
transplanted back into the mouse. These homing properties however become lost 
after culture for both human (146) and mouse (270)) MSC. More recent work 
suggests that targeting of MSC to specific tissues can be influenced via homing 
signals expressed by for example an injured tissue (22,169). To date, the question of 
MSC circulation is still a matter of controversy and more work is needed to solve 
this question.  
 
 
1.3.7 Hox genes and MSC 
It is still largely unknown what gene expression programs and external cues are 
responsible for regulating proliferation, self-renewal, homing, differentiation and 
tissue-specific differences of MSC. We specifically became interested in the 
question how tissue-specific properties become established in vivo and how they are 
maintained in vitro and in vivo. An interesting group of candidate genes that might 
play a role in this establishment of tissue specific cell identity are the Hox genes. 
Hox genes are widely expressed in mammals in a variety of tissues and organs, 
during both embryonic development and adult life (reviewed by Morgan (216)). 
They play important roles in tissue specification and cell identity during embryonic 
development, and likely also continue this role during adult life.  Fibroblasts from 
different parts of the body express specific sets of Hox genes (47,266). It was 
suggesteds that combinations of Hox genes may provide cells in the adult with a 
lasting topographic “address”, and control region-specific functions in the adult 
body, analogous to their embryonic function. Hox genes are expressed in both fetal 
and adult derived MSC (2,108,243,331) and it is conceivable that they might be 
involved in encoding tissue-specific properties of MSC.  
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1.4 Hox Genes  
Hox genes encode a family of transcription factors, and are organized in 
evolutionarily conserved clusters in the genome. They can be found in many species 
and have been identified in all studied bilateral animals and cnidarians. Hox genes 
were first recognized for their important functions during embryonic development. 
This was initially studied in Drosophila melanogaster by discovery of the Homeotic 
complex (HOM-C). Incorrect expression of HOM-C genes can lead to drastic 
changes in body morphology (homeotic transformations), in which one specific 
body segment or structure transformed into the likeness of another (186).  
The HOM-C is the Drosophila homolog of the mammalian Hox clusters, and the 
chromosomal positioning of the HOM-C genes is strikingly similar to the Hox genes 
in mammals. However, whereas Drosophila only contains one HOM-C, split over 
two clusters, mammalian genomes contain four copies of its Hox cluster (A-D), 
thought to be derived through cluster duplication during evolution with some loss of 
individual genes (166). These four clusters contain a total of 39 genes subdivided in 
13 paralogue groups (Figure 2).  
Hox/HOM genes play an instrumental role during embryonic development. Despite 
large differences that exist between Drosophila and mammalian embryonic 
development, a lot of knowledge concerning gene structure, expression and function 
of mammalian Hox genes is derived from studying the role of HOM-C genes in 
anterior-posterior axis formation in Drosophila (185,204). Like HOM-C genes, Hox 
genes play an important role in embryonic patterning in which embryonic cells form 
ordered arrangements of differentiated cells to construct functional tissues and 
organs.  
 
 
 
Figure 2. The Hox/Hom clusters 
A schematic view of the 4 mammalian Hox clusters in comparison to the single 
homologous Drosophila HOM-C. Arrows represent Hox genes and their direction of 
transcription. The colors correspond to the various paralogy groups. These genes are 
most closely related in sequence, and are derived from a common ancestral Hox 
gene. 
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1.5 Colinearity 
Looking at the genomic arrangement of the Hox clusters, a colinear relationship can 
be recognized between the physical gene order along the chromosome and their 
anterior boundary of expression and function along the developing embryonic body 
axis (77,111,158,186). In mammals, this colinear gene activation results in 
combinatorial expression of subsets of Hox genes in specific areas along the body 
axes that are translated into a regional identity. This specific regional expression 
coincides with a functional hierarchy, in which the products of more posteriorly 
expressed genes are often functionally dominant over the anteriorly expressed genes. 
This phenomenon is referred to as posterior prevalence (75). The combination of 
functionally active Hox genes that specifies a specific tissue or (vertebral) segment, 
is often referred to with the term: Hox code (157). 
Several types of colinear expression have been described (158). First, spatial 
colinearity refers to the ordered array of spatially restricted domains in for example 
the paraxial mesoderm (77,111), neural tube (42), limbs (148,348), Müllerian 
system (312) and gastrointestinal tract (156,249), in which 3’ genes (Hox1, 2, 3 etc) 
are expressed more anteriorly than the 5’ genes (Hox11, 12, 13) of the gene clusters. 
Second, temporal colinearity refers to the timing of gene expression during 
embryogenesis in which 3’ genes are expressed earlier than the 5’ genes of the gene 
clusters (140).  
The Hox code is not only determined by the presence or absence of Hox proteins, 
but also by their relative expression levels (112). During limb development, 5’ Hoxd 
genes show an increasingly higher level of expression than the subsequent 
neighboring 3’ genes. This phenomenon is termed quantitative (reverse) colinearity 
(159).  
 
 
1.6 Gene Regulation 
Within the Hox gene clusters, the tight genomic organization is extremely important 
for correctly coordinated regulation of gene expression. It is also suggested that the 
clusters are kept together due to sharing of evolutionarily conserved regulatory 
elements that are instrumental for expression of the genes (76). Despite tremendous 
advances in the field, several questions on how gene expression is exactly initiated 
and maintained are still unanswered.  
Gene transcription is a complex multi-level process that is not only dependent on the 
availability of transcription factors and RNA polymerase II, but also by the context 
of the chromatin and the cell-cycle stage. Eukaryotic genomes are organized into 
condensed, heterogeneous chromatin fibers throughout most of the cell cycle. 
Nucleosomes are the fundamental structural units of chromatin. They are comprised 
of a core histone octamer (H2A, H2B, H3, and H4), around which the associated 
DNA is wrapped. In order for the transcriptional machinery to access the DNA 
template, the packaging of eukaryotic DNA into nucleosomal arrays must be 
modified towards a transcriptionally active or ‘open’ state. Dynamic changes in 
chromatin folding can influence the availability of a gene to the transcription 
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machinery.  The chromatin state is directly influenced by post-translational 
modifications of the amino-terminal tails of histones by remodeling enzymes that 
control the dynamics of chromatin folding (131,263).After a gene has been released 
from its 'closed' chromatin state, transcription is influenced by changes in nuclear 
concentrations of activator and repressor proteins that bind the DNA at specific 
binding sites. In mammals, every gene usually has its own promoter. This is a 
stretch of DNA sequence that is found directly upstream of the coding DNA and to 
which specific factors required for gene transcription bind. Transcription starts with 
the binding of the pre-initiation complex (PIC) to the promoter, followed by RNA 
polymerase II recruitment, which is responsible for the production of the messenger 
RNA. The PIC is a collection of transcription factors that assembles and stabilizes 
on specific recognition sequences that are present in the promoter (217). Promoter 
sequences often display little or no tissue specificity. Expression specificity is 
usually regulated by specialized cis-regulatory elements that either enhance the basal 
transcription of a promoter (enhancers) or repress the transcription (silencers/ 
repressors). These regulatory elements are basically a collection of protein 
recognition sites to which transcription factors can bind. Structurally they are very 
similar to promoters but lack a transcription start site. Enhancers do not follow a 
simple rule with respect to their location relative to the promoters. They can be 
found upstream (5’), downstream (3’), overlapping with promoters or in the intron 
of a gene. Enhancers can be very promiscuous in their promoter activation, but they 
can also be highly specific for a promoter and/or tissue (67,89,297).  
To investigate Hox gene regulation, numerous transgenic and deletion experiments 
in the mouse have revealed the presence of both local and long distant cis-regulatory 
elements. These elements are involved in the control of tissue and cell specific 
expression, and can be responsible for the establishment of collinear expression by 
specification of the expression boundaries in the developing embryo (202,299,300). 
Most of this research has focused on elucidating the regulation of Hox gene 
expression during development. Hox gene regulation in the adult mammal on the 
other hand, is still an unexplored field. 
 
 
1.6.1  Regulation of colinear expression  
Hox gene expression can roughly be resolved into three overlapping phases: 
initiation, establishment and maintenance (71). Transcription initiation is thought to 
involve the binding of factors in the proximity of the Hox clusters that enables 
chromatin opening, and allows gene transcription. After initiation the Hox genes are 
sequentially activated to form well established expression domains, which are 
subsequently maintained through epigenetic mechanisms. Because most factors, as 
described below, that are thought to initiate Hox gene expression also play a role in 
establishment of the expression domains these phases are discussed together. 
 
 
Initiation and establishment 
It has been suggested that the Hox clusters undergo a progressive decondensation of 
the chromatin structure from 3′ to 5′ via, for example the progressive release from a 
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silenced state. This would allow increasing numbers of Hox genes to be activated 
while preventing posterior genes from being expressed too early during embryonic 
development. The precise nature of the underlying mechanisms however, is still to 
be established (46,158).  
The most extensively studied potential activator of Hox gene expression initiation in 
the fetal hindbrain is retinoic acid (RA) (105). Hox genes in both embryonic 
presomitic mesoderm as well as cell lines respond with a colinear sensitivity in level 
and time to increased RA levels (175,200,234,247,290,291). However, whether 
retinoids are actually involved in the initial activation of the Hox genes in the 
primitive streak or only act in a later stage to regulate mesoderm segmentation is not 
completely clear (200,214,269). 
Retinoids may act as ligands to activate two families of nuclear receptors, the RA 
receptors (RARα, β and γ), and the retinoid X receptors (RXRα, β and γ). 
These nuclear receptors recognize cis-acting DNA sequences called retinoic acid 
response elements (RAREs) and heterodimerize on these target sites (115). Several 
clusters of RAREs can be found in the vicinity of 3’ Hox genes (196) and it has been 
speculated that these play a role in the initiation of Hox gene expression by inducing 
chromatin decondensation and nuclear re-organization by extrusion of the genes out 
of their chromosome territory (46). However, for most of the potential RAREs their 
direct involvement in regulation of Hox gene expression has not been studied yet. 
 
Recently it had been described that transcription in the Hox clusters shows a high 
complexity in both human and mouse. Unannotated non-coding transcripts can 
represent up to 60% of the total transcriptional output of a cluster and can be found 
on both sense and antisense strands (197). Addition of RA to cultured cells triggers 
this transcription of non-coding RNA (ncRNA) within the HoxA cluster (44,284). It 
has been hypothesized that production of non-coding transcription in regulatory 
regions of the HoxA cluster is involved in a RA-induced transcription activation 
process. The transcribed sequences are not conserved in evolution, and the 
transcribed sequences themselves do not have a direct regulatory effect on Hox gene 
activation (284). After chromatin decondensation, ncRNA expression within the 
clusters might play a role in transcription establishment of Hox genes by forcing an 
open chromatin state and allowing the activation of cis-regulatory elements 
(26,267,274,281,284), although transcriptional interference of ncRNA has also been 
reported (240,267). The actual function of these transcripts is still to be resolved. 
In contrast, naturally occurring microRNAs (miRNAs) constitute a powerful route to 
dynamically silence specific gene expression programs by either translational 
inhibition or direct RNA degradation. Two conserved miRNA loci have been 
identified in the Hox clusters and their target sequences are present in the 3′-UTR of 
neighboring Hox genes. These miRNAs are expressed in embryos in a spatial pattern 
that is suggestive for a role opposing Hox gene expression (198,344). However, the 
actual functional contribution of miRNAs to Hox regulation has not been 
demonstrated yet.  
 
Several other proteins that play an important role in the anteroposterior patterning of 
the embryo have been implicated in Hox gene activation. These include factors like 
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FGF, WNT and CDX proteins. The pathways in which these proteins act seem to 
contribute to RA receptor activation during somitogenesis, and could potentially 
influence the expression boundaries of Hox genes (24,72,79). Transcription of Hox 
genes in the presomitic mesoderm shows a coincidence with the dynamic expression 
of members of the Notch signaling pathway and it has been suggested that Hox 
genes are under influence of the segmentation clock (78,349).  However there is as 
yet very little evidence of factors that directly interact with Hox genes. 
 
 
Maintenance 
As mentioned previously, the context of the chromatin is very important in the 
process of gene expression. Chromatin structure is predominantly regulated through 
a set of posttranslational histone modifications such as methylation, acetylation, 
phosphorylation and ubiquitination (165). Studies of such histone modifications 
have suggested that the chromatin state contributes to the specification and 
maintenance of cell identity.  
 
Posttranslational histone modifications catalyzed by trithorax group (trxG) proteins 
or 
Polycomb group (PcG) proteins play important roles in dividing the genome into 
transcriptionally active and silent areas, respectively. These proteins work 
antagonistically via PcG or trxG response elements (PRE/TRE), which are specific 
DNA binding sites for these protein complexes (25) (265,298). Their enzymatic 
activities place epigenetic marks that are thought to propagate transcriptional 
memory from one cell generation to the next. PcG and TrxG proteins are found in 
multi-protein complexes, containing both histone methyltransferase activity, as well 
as proteins that bind methylated histone lysine residues. There are at least two 
distinct PcG complexes in mice. PcG repressive complex 1 (PRC1) contains Cbx, 
Mph, Ring, Bmi1, and Mel18. PRC2 (also termed EED-EZH2) contains Ezh2, Eed, 
and Su(z)12 (188). 
Mutations in PcG genes lead to ectopic Hox gene expression and consequent 
posterior homeotic transformations in both Drosophila and vertebrates. Long-term 
repression of Hox genes is modulated by PRC2 mediated histone H3 methylation. 
Subsequent recruitment of PRC1 members then promotes condensation of the 
chromatin structure in which ubiquitination of histone H2 by PRC1 is supposed to 
be an essential step in Hox gene silencing (40).  
Recently, a new family of histone H3 demethylases that oppose PcG mediated 
silencing was identified at Hox promoters during differentiation of stem cells. The 
recruitment of UTX and JMJD3 demethylases to the promoters of Hox genes seems 
to be required either for the transcriptional activation during differentiation of stem 
cells, or for the maintenance of expression in lineage-committed cells (3,4). 
 
In comparison to PcG proteins relatively little is known about the mammalian TrxG 
protein complexes. Several complexes that contain TrxG proteins have been purified 
from Drosophila embryos, all with different chromatin-modifying properties 
involving methylation of H3 (195,293). In mice and humans however, there is only 
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limited knowledge involving some members of the SWI/SNF complex and the Mll 
protein (also named Mll1, All-1 and Hrx). The human SWI/SNF complex has been 
implicated in gene activation by a variety of activators, suggesting a broad function 
in control of gene expression (11) but so far no direct effect on Hox gene regulation 
has been described.  
Mll is the homolog of Drosophila trx and can be part of in a huge protein complex 
with more than 20 partners (222). In contrast to SWI/SNF members, Mll has been 
implicated in Hox maintenance, and loss of the Mll protein is associated with a loss 
of Hox gene expression (121,250,342,346). MLL is able to bind specifically to Hox 
promoters and activates expression (208,222). On the other hand it also binds to a 
large domain within the transcriptionally active region of the HOXA cluster, which 
is thought to function in Hox gene maintenance and cell identity (116). 
 
1.7 Function of Hox proteins 
A common feature of homeobox proteins is the presence of the homeodomain. The 
Hox gene family belongs to the superclass of homeobox genes. The human genome 
contains over 200 predicted functional homeobox genes divided between 102 gene 
families (129). The homeodomain is a 60-amino-acid motif, which is highly 
conserved in evolution and present in proteins of fungi, plants, and animals. Proteins 
containing a homeodomain are usually classified as transcription factors. 
Homeobox proteins modulate transcription through specifically recognised DNA 
recognition sites to which the homeodomain binds (101,102). However, Hox 
proteins display surprisingly weak DNA binding properties to the predicted 
recognition sites. In order to exert their function, Hox proteins often need to interact 
with other DNA-binding proteins, which act as cofactors. The cofactors that have 
been identified so far all belong to the PBC and MEIS classes of TALE (Three 
Amino acid Loop Extension) homeodomain proteins (212). It has turned out to be 
very difficult to predict potential interactions between Hox proteins and their 
cofactors. In addition, cofactor dependence also complicates the possibility to 
predict potential Hox target genes on the basis of protein recognition sites in the 
DNA. As a result only very few direct interactions of Hox proteins with target genes 
have been reported (182,306). However, despite the lack of knowledge with regards 
to target genes a substantial body of knowledge has been accumulated about the 
roles of Hox proteins within many pathways during both embryonic development 
(as described above) as well as some functions in the adult animal.  
1.7.1 Function in adulthood 
Hox genes continue to be expressed in the adult (216) where they seem to have 
partially maintained a spatial colinearity in which posterior tissues express more 
Hox genes compared with anterior tissues (47,266,308,343). For example during 
adult life, Hox genes are essential for processes like cyclic endometrial development 
and for endometrial receptivity in which also some colinear expression was reported 
(5,312). Hox proteins may be involved in skin repair (191) and it was hypothesized 
that they contribute to the positional identity that upon injury, influences the 
regeneration of the correct skin type in a certain location (268,282). Besides 
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functioning in (colinear) patterning processes, their function also extends to some 
non-colinear processes related to cell-identity during differentiation. This can for 
example be seen in hematopoiesis (1,193,316) and hair follicle morphogenesis (14) 
in which several Hox proteins play a role in the regulation of normal cellular 
proliferation and differentiation. As expected from proteins involved in 
proliferation, deregulation of Hox gene expression in adult tissues is often correlated 
with cancer (114), which has mostly been studied for hematopoietic malignancies 
(232). However, the function of most Hox gene expression detected in adult cell 
types and organs is not known. It is also unclear whether the Hox expression in adult 
mammals is the maintenance of some embryonic patterns, or is established 
postnatally to accomodate Hox functions in specific adult processes. Extensive 
regulatory and functional studies are required to answer this question. 
 
 
1.8 Outline of this thesis 
We hypothesised that Hox proteins may play a role in the establishment of regional 
differences between different MSC isolates. The first step in understanding the 
potential function and regulation of Hox genes in MSC is to establish their exact 
expression patterns. We have mapped Hox gene expression in MSC from different 
sites of the body. The resulting expression profiles could then be compared to their 
anatomical origin and their differentiation potential. This showed that Hox genes in 
MSC are expressed in region specific patterns  (Chapter 2). Having established the 
expression patterns for all Hox genes in the MSC, we attempted to identify the 
responsible regulatory elements. These elements may be located either outside of or 
within the Hox clusters. By expressing differently sized Hox constructs we have 
narrowed down some regions that might play a role in activation and regulation of 
Hox gene expression in MSC (Chapter 3). In a parallel approach, we have 
attempted to identify enhancer elements responsible for Hox gene expression in 
hematopoietic cells. Hox proteins play an important role in proliferation and 
differentiation of a variety of hematopoietic lineages. We showed that the elements 
that are responsible for expression of HOXA genes in hematopoietic cells are most 
likely located at a remote position outside the cluster. Also we developed an assay, 
which could potentially lead to the identification of these elusive elements (Chapter 
4). 
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2.1 Summary 
Mesenchymal stem cells (MSC) are multipotent cells found as part of the stromal 
compartment of the bone marrow and in many other organs. They can be identified 
in vitro as CFU-F (colony forming unit-fibroblast) based on their ability to form 
adherent colonies of fibroblast-like cells in culture. MSC expanded in vitro retain 
characteristics appropriate to their tissue of origin. This is reflected in their 
propensity for differentiating towards specific lineages, and their capacity to 
generate, upon retransplantation in vivo, a stroma supporting typical lineages of 
hematopoietic cells. Hox genes encode master regulators of regional specification 
and organ development in the embryo and are widely expressed in the adult. We 
investigated whether they could be involved in determining tissue-specific 
properties of MSC. Hox gene expression profiles of individual CFU-F colonies 
derived from various organs and anatomical locations were generated, and the 
relatedness between these profiles was determined using hierarchical cluster 
analysis. This revealed that CFU-F have characteristic Hox expression signatures 
that are heterogeneous but highly specific for their anatomical origin. The 
topographic specificity of these Hox codes is maintained during differentiation, 
suggesting that they are an intrinsic property of MSC. Analysis of Hox codes of 
CFU-F from vertebral bone marrow suggests that MSC originate over a large part of 
the anterioposterior axis, but may not originate from prevertebral mesenchyme. 
These data are consistent with a role for Hox proteins in specifying cellular identity 
of MSC. 
 
 
2.2 Introduction 
Adult mammals have limited capacity for regenerating lost tissues. Yet, many 
organs contain populations of multipotent stem cells that are capable of regenerating 
specialized cell types under certain conditions and that might offer perspectives for 
regenerative medicine, although relatively few of these have established roles in 
normal tissue homeostasis and repair. In addition, essentially all organs and tissues 
tested contain so-called mesenchymal stem cells (MSC). MSC were first identified 
by the pioneering work of Friedenstein and coworkers as a small population of 
osteoblast progenitor cells in bone marrow, which are normally quiescent but can 
undergo self-renewal in vivo (reviewed by Phinney (241)). They could be assayed in 
vitro as CFU-F (colony-forming unit-fibroblast), based on their ability to form 
colonies of adherent fibroblastoid cells in culture (92). Subsequently, work by 
several groups showed that CFU-F colonies contain multipotent cells that can be 
expanded in vitro while retaining the potential to differentiate into several 
mesenchymal cell types including osteoblasts, chondrocytes, and adipocytes 
(reviewed by Prockop (253)). Because of this capacity and because of their 
immunomodulatory properties (see review by Rasmusson (260)), MSC have great 
clinical potential for tissue engineering and repair, and as a vehicle for gene therapy 
strategies (reviewed by Prockop (254)). 
MSC display remarkably tissue-specific regenerative potential when tested in 
appropriate in vivo assays. Thus, bone marrow MSC transplanted under the kidney 
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capsule can generate a bone and marrow organ that supports hematopoiesis by 
invading host-derived myeloid progenitors. In contrast, MSC from spleen generate a 
reticular stroma that primarily supports lymphopoiesis (94). Furthermore, bone 
marrow but not thymus MSC spontaneously differentiate into bone when 
transplanted intraperitoneally in diffusion chambers (90). In vitro, MSC from 
different organs also exhibit intrinsic differences in proliferative capacity and in the 
efficiencies with which they can be induced to differentiate towards specific 
mesenchymal lineages (65,136,273). 
 
 It is unclear how tissue-specific differentiation programs are regulated in MSC. 
Prime candidates are the members of the Hox family of transcription factors, which 
are master regulators of regional specification during embryonic development 
(reviewed by McGinnis and Krumlauf (204)). The 39 mammalian Hox genes are 
organized in four paralogous gene clusters located on different chromosomes. They 
are expressed during embryogenesis in a coordinated manner, resulting in 
overlapping, regionally restricted domains of expression. These expression patterns 
are characterized by an evolutionarily conserved correlation, termed colinearity, 
between the physical order of the genes within the clusters, and their anterior limits 
of expression. Thus, genes located more 3' in the cluster are expressed more 
anteriorly than more 5' genes (reviewed by McGinnis and Krumlauf (204)). Hox 
genes continue to be expressed in the adult in many organs (reviewed by Morgan 
(216)). Also, fibroblasts from different parts of the body express specific sets of 
genes including Hox genes (47,266). These data suggest that combinations of Hox 
genes may provide cells in the adult with a lasting topographic “address”, and 
control region-specific functions in the adult body, analogous to the embryonic “Hox 
codes” (157) specifying regional differences in development. 
 
The developmental origin of MSC is largely unexplored. In the mouse embryo, 
CFU-F can be found as early as embryonic day (E)11.5 (206,324), but lineal 
relationships between embryonic and adult CFU-F have not been established. As 
Hox genes are expressed in fetal as well as adult MSC (108,243,331), we embarked 
on a profiling study of Hox gene expression in CFU-F colonies derived from 
different organs, expecting to gain insight into (i) the lineage relationships among 
MSC, and (ii) the putative role of Hox proteins in modulating tissue-specific 
properties of MSC. In this study we show that CFU-F-derived fibroblasts have 
specific Hox gene expression signatures that correlate with their anatomical origin 
and suggest that CFU-F originate along a large part of the anteroposterior axis. We 
investigate how Hox gene expression is influenced by cell-extrinsic factors in CFU-
F cultures, and find that CFU-F Hox codes are a largely intrinsic property of MSC. 
These data are consistent with a role for Hox proteins in determining cellular 
identity of MSC. 
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2.4 Results 
Distinct Hox gene expression signatures in CFU-F colonies from different 
locations 
To gain insight into the putative role of Hox proteins in establishing tissue-specific 
properties of MSC, and to obtain clues about the origin of MSC in the embryo, we 
investigated whether Hox genes are differentially expressed by CFU-F from 
different organs and anatomical locations. For this study we used primary CFU-F 
colonies, which, though comprising a heterogeneous collection of CFU-F-derived 
progeny with an admixture of non-fibroblastic, primarily hematopoietic cells 
(discussed by Prockop (253) and Prockop et al (254); and see below), represent the 
closest approximation to the individual CFU-F that is amenable to gene expression 
profiling. Seeding densities and CFU-F frequencies for the tissues analyzed are 
listed in Table 1. 
 
 
Table 1. Plating conditions and CFU-F frequencies. 
Tissue 
of 
origin 
Seeding density 
(x104 nucleated 
cells /cm2) 
Number of CFU-F 
colonies per 20cm2 
plate ¶ 
Average CFU-F 
frequency (/106 
nucleated cells) 
Lung 10 2; 5 2 
Thymus 100 19; 24 1 
BM - sternum 5 16; 16; 18; 9 15 
5 4; 8; 10; 12 9 
BM - forelimb 
10 13; 32 11 
BM - femur 10 21; 23; 24; 28; 35 13 
BM - tibia 10 18; 21 10 
¶ numbers presented are a typical set of data obtained in a single experiment (i.e., 
experiment 2 described here) 
   
 
Initially, we derived an average expression profile by pooling cDNA from several 
colonies (pools P1 and P2 representing two independent experiments, see Fig. 1). 
This analysis revealed that genes from all four Hox clusters are expressed in CFU-F 
colonies, in complex patterns that are different according to their origin (Fig. 1). 
These differences were reproducible, as P1 and P2 profiles of colonies from the 
same location were largely in agreement. Since clonally expanded CFU-F from the 
same tissue can exhibit considerable heterogeneity in differentiation potential and 
gene expression (93,171,189), we investigated whether differences between P1 and 
P2 could be due to these pools having been sampled from a population of CFU-F 
colonies that is heterogeneous also with respect to Hox gene expression. 
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Figure 1. Hox gene expression profiles of CFU-F from different tissues.  
Gene expression was analyzed in cDNA pools comprising six to twenty-one individual 
colonies as indicated (n=..), P1 and P2 representing pools of colonies isolated in 
independent experiments. 
 
 
Thus, we determined Hox gene expression profiles for each individual CFU-F 
colony represented in the P2 pools. To objectively assess the degree of similarity 
between these profiles, hierarchical clustering was applied to the single-colony 
profiles as well as the averaged profiles P1 and P2, resulting in the dendrogram 
shown in Fig. 2. This analysis revealed significant heterogeneity among CFU-F 
colonies from each of the different locations; nevertheless, the vast majority of 
expression patterns segregated into coherent groups representing different tissues of 
origin. This was evident when the dendrogram was cut at a level yielding five 
clusters, comprising four major clusters representing sternum, forelimb, hindlimb 
and lung/thymus (Fig. 2). 
A few profiles ended up in the "wrong" cluster (Thymus 10, Thymus 7 and Forelimb 
13 in the sternum cluster) or outside any of the four main anatomical clusters (Femur 
1 and Femur 2). Whether this is due to natural variation in gene expression, or rather 
to technical issues, cannot be determined based on the present data. Due to the 
limited amount of cDNA obtained from individual colonies, replication of PCR 
assays was not possible. However, retrospective analysis of the data (see 
Supplemental data, Table S2) suggested that on the whole, expression levels in 
individual colonies were well above the limit of detection, which is corroborated by 
the reproducibility of the P1 and P2 PCRs (see Materials and Methods). This 
analysis also suggested that expression profiles of pooled cDNAs represent a 
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weighted average of the expression in individual colonies. We conclude that the 
heterogeneity observed is likely to be biological in origin, which is in line with the 
known functional heterogeneity among CFU-F colonies. Importantly, all expression 
profiles P1 and P2 were located within their corresponding clusters, indicating that 
they are representative of the single-colony profiles in their clusters. 
Within their cluster, CFU-F profiles from lung and thymus formed clearly distinct 
groups, in contrast to those from tibia and femur, which were completely dispersed 
within a common hindlimb cluster. By cutting the linkage dendrogram at a different 
level, lung and thymus CFU-F profiles could be segregated into two distinct and 
coherent clusters; however, this also caused other clusters to break up into 
subclusters (data not shown). This indicates that Hox expression profiles of lung and 
thymus CFU-F colonies represent distinct identities, but that the difference between 
them is small compared to the degree of heterogeneity existing within other clusters. 
Tibia and femur profiles, in contrast, did not partition into two homogeneous 
clusters at any level of the linkage tree (data not shown). Surprisingly, CFU-F 
colonies from the bone marrow of sternum, forelimb and hindlimb yielded distinct 
Hox signatures, demonstrating that the type of tissue is not the only determinant of 
the expression profile, and suggesting that topographical location is an additional, 
possibly the primary factor underlying these differences in expression. 
 
  
Influence of hematopoietic cells on Hox gene expression 
In agreement with the literature, most CFU-F colonies contained hematopoietic 
cells, as revealed by expression of the pan-hematopoietic marker CD45 (Ptprc; data 
not shown). Proliferation of CFU-F fibroblasts in vitro is known to be dependent on 
the presence of hematopoietic cells in the culture (18,97,170). The presence of 
hematopoietic cells might affect CFU-F Hox gene expression profiles in different 
ways. Firstly, signals from hematopoietic cells might influence transcriptional 
regulation of Hox genes in the fibroblasts. Secondly, since hematopoietic cells also 
express Hox genes, albeit at low levels (supplementary material of (30); our 
unpublished observations), they could contribute to the expression profiles in a 
direct manner. To evaluate the contribution of hematopoietic cells, fully formed 
CFU-F colonies from sternum and forelimb were depleted of hematopoietic cells 
using ATP-mediated cyanide poisoning (211). This effectively removed all 
hematopoietic cells from the cultures as determined by microscopic observation (see 
Fig. 3A), by FACS analysis using antibodies against CD45 (data not shown), and by 
RT-PCR detection of Ptprc mRNA (Fig. 3B). In agreement with previous reports 
(18,170,211), depleted colonies maintained in culture stopped expanding and 
eventually detached from the substrate after several days. Also, depleted fibroblasts 
could not be replated upon trypsinization, whereas untreated cells could be passaged 
repeatedly (data not shown). At the time of harvesting however, viability of the 
fibroblasts was not significantly compromised, as determined by FACS analysis of 
cells stained with 7-amino-actinomycin D (data not shown).  
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Figure 2. Hierarchical clustering of Hox gene expression profiles.  
(A) Cluster analysis of Hox gene expression profiles of individual colonies and pooled 
cDNAs (black boxes). Profile names and colors indicate the tissue of origin, and gene 
expression was scored as expressed (red) or not detected (blue). The linkage 
dendrogram shown on the left was cut at a level yielding five clusters, indicated by 
brackets. (B) Expression of differentiation markers in the samples. These expression data 
were not used in the cluster analysis. 
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Expression of a subset of Hox genes, including genes differentially expressed in 
CFU-F colonies from these two tissues, genes expressed in both, and one gene 
expressed in neither, was analyzed in cDNA pooled from six colonies per tissue. All 
of these genes were expressed in qualitatively identical patterns in depleted and non-
depleted CFU-F colonies (Fig. 3C). These data strongly suggest that the Hox profiles 
obtained faithfully reflect expression in CFU-F fibroblasts, and are independent of 
the presence of hematopoietic cells. 
 
 
Figure 3. Contribution of hematopoietic cells to Hox gene expression profiles.  
CFU-F colonies from forelimb and sternum bone marrow were depleted of 
hematopoietic cells, and gene expression was compared in pools of six cDNAs of 
depleted and non-depleted colonies from each location. (A), microscopic phase 
contrast images showing part of a non-depleted and a depleted colony. Note 
absence of birefringent hematopoietic cells on top of the fibroblast monolayer after 
depletion. (B), RT-PCR detection of Ptprc (CD45) mRNA in depleted and non-depleted 
colonies, compared with expression in a cDNA preparation of total bone marrow (TBM). 
(C), expression of selected Hox genes in depleted and non-depleted colonies of 
forelimb and sternum. 
 
 
Hox gene expression and differentiation 
A certain amount of spontaneous differentiation is known to occur during culture of 
CFU-F, and it has been shown that single, clonal CFU-F colonies can 
simultaneously express markers for several different lineages (320,338). The smooth 
muscle marker Tagln (SM22α) was expressed in all CFU-F colonies, whereas 
expression of the chondrogenic and adipogenic lineage markers aggrecan and 
adipsin, respectively, was rarely observed (see Fig. 2B). Expression of the 
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osteogenic lineage marker bone sialoprotein (Bsp) on the other hand was detected in 
most bone marrow-derived CFU-F colonies but in none of the lung or thymus 
colonies (Fig. 2B). This suggests that CFU-F from bone marrow and non-bone 
marrow tissues have different propensities for differentiation along the osteogenic 
lineage, which agrees with previous in vitro and in vivo data (92,96). 
 
Some Hox genes are differentially regulated during osteogenic (20,104,123,257,287) 
or adipogenic (60) differentiation. Therefore, we asked whether Hox profiles depend 
on the differentiation status of the cells, and in particular whether differences 
between bone-marrow and non-bone marrow Hox profiles could be attributed to the 
osteogenic differentiation that occurs in bone marrow CFU-F colonies. High-density 
CFU-F cultures were subjected to osteogenic and adipogenic differentiation 
conditions. As has been observed by others (65,136,273), cultures from different 
organs varied markedly with respect to the degree of terminal differentiation as 
determined by histochemical staining (see Fig. 4A). Interestingly, this was also true 
for bone marrow from different bones: CFU-F cultures from forelimb consistently 
differentiated poorly towards bone as well as fat. Not all of these differences were 
reflected in the levels of marker gene expression (Fig. 4B). Undifferentiated cells 
from all five sources expressed the early adipogenic marker PPARγ2, while 
expression of the late adipogenic marker adipsin showed the same tissue distribution 
as was observed for individual CFU-F colonies (Fig. 2). In contrast, the early and 
late osteogenic markers Runx2 and osteocalcin, respectively, were already expressed 
prior to induction of differentiation, in all of the cultures. This is most likely due to 
the higher cell densities in these cultures, since osteogenesis as detected by alkaline 
phosphatase staining is commonly observed in the dense center of CFU-F colonies 
(231) where proliferation ceases (231). 
 
Hox expression profiles of undifferentiated cells resembled those of the 
corresponding P1 and P2 pools of CFU-F colonies (Fig. 4C, cf. Fig. 1; and data not 
shown). However, under these culture conditions expression of some genes, namely 
Hoxa6, Hoxa7, Hoxc8 and Hoxc9, and to a minor extent also Hoxa10, was no longer 
bone marrow-specific, as they were also detected in lung and thymus cultures (Fig. 
4, cf. Fig. 1; data not shown). This correlated with the expression of osteogenic 
marker genes in the latter cultures as described above. Nevertheless, during the 
subsequent three weeks of culture under differentiation-inducing conditions, the Hox 
codes for all five tissues remained unchanged compared to those of the 
undifferentiated cells (Fig. 4C, and data not shown), showing that topographic 
distinctions are maintained during terminal differentiation. 
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Figure 4. Regulation of Hox genes during differentiation.  
CFU-F cultures from different tissues were analyzed before (-) and after 21 days of 
culture under osteogenic (O) or adipogenic (A) conditions. (A) Results of histochemical 
staining with Alizarin Red (for cultures in osteogenic differentiation medium) or Oil red O 
(for cultures in adipogenic differentiation medium). (+/- indicates that very few cells 
were stained.) (B) Expression of differentiation markers. (C) Expression of the Hoxa 
cluster. 
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Do CFU-F Hox codes reflect embryonic patterning of the body plan? 
As Hox gene expression in the adult frequently follows expression patterns 
established in the embryo (216), we wondered whether the Hox codes observed in 
CFU-F colonies reflect the embryonic expression patterns of Hox genes in the 
corresponding tissue primordia. Making meaningful comparisons is hampered by the 
diverse and complex origins of the different organs under investigation, the often 
dynamic expression of Hox genes therein, and our lack of knowledge of the 
temporal appearance and lineal origin of CFU-F. To obtain a more clear-cut picture, 
we turned to the vertebrae, which are serial homologues with straightforward 
topographical relationships. They are formed from somitic mesoderm in a well-
defined manner (reviewed by Christ et al. (55)), and are individualized at an early 
stage as prevertebral condensations of mesenchyme. Furthermore, expression of Hox 
genes in prevertebrae has been extensively documented. Hence, we asked whether 
Hox profiles of CFU-F from vertebral bone marrow correspond to the Hox codes 
observed in the embryonic prevertebrae (157). 
 
Many vertebrae turned out to contain sufficient bone marrow for small-scale CFU-F 
cultures to be established. Hox profiles derived from such cultures displayed a 
remarkable degree of spatial colinearity, although with several exceptions to the rule 
that successively more 5’ genes within a cluster are expressed increasingly less 
anteriorly, (Fig. 5A, grey bars). When these expression patterns are compared to the 
anterior boundaries of expression in the prevertebrae reported in the literature 
(vertical tacks in Fig. 5A), many discrepancies are apparent. For twenty genes it was 
possible to compare the expression boundary in prevertebrae with that in CFU-F 
cultures. Interestingly, within this group of genes, those from the 3’ half of the 
clusters exhibited more posterior expression boundaries in vertebral CFU-F cultures 
than in the corresponding prevertebrae whereas, in contrast, more 5’ paralog groups 
tended to show increasingly more anterior expression in CFU-F cultures than in the 
prevertebrae (see Fig. 5B). Clearly, these data are not consistent with a 
straightforward derivation of CFU-F Hox profiles from prevertebral Hox codes. 
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Figure 5. Hox gene expression in CFU-F from vertebral bone marrow.  
(A) Expression domains of Hox genes in CFU-F. The vertebral column is represented 
schematically at the top of the panel, with the first cervical, thoracic, lumbar, sacral 
and caudal vertebrae (C1, T1, L1, S1 and Ca1, respectively) indicated above and the 
corresponding prevertebral numbers (pv #) below. Color-coding of vertebrae: green, 
CFU-F Hox gene expression profile successfully derived; white, insufficient bone marrow 
to establish a culture; grey, quality of cDNA was insufficient for expression profiling. The 
colored horizontal bars represent the anteroposterior domains of Hox gene expression in 
CFU-F as determined from the Hox profiles of cultures from individual vertebrae. Black 
vertical tacks indicate the anterior limits of gene expression in embryonic prevertebrae 
at E11.5 – E12.5, as reported in the literature, determined by in situ hybridization on 
sections using radioactively labeled probes. Arrowheads indicate that prevertebral 
expression boundaries lie more anteriorly than pv1. *, not expressed in prevertebrae at 
these stages. (B) Difference between the anterior boundaries of the expression domains 
in vertebral CFU-F [b(CFU-F)] and in the prevertebrae [b(pv)]. Circles indicate a defined 
difference, arrowheads indicate a minimum difference, as deduced from the data in 
panel A. 
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2.4 Discussion 
Topographic Hox codes in CFU-F colonies 
It has long been recognized that MSC from different organs are different in many 
respects. Differential expression of some Hox genes in CFU-F cultures from 
different tissues has been observed in one previous gene expression profiling study 
(108). Here, we provide here the first evidence that MSC possess, or acquire during 
explantation and culture, a complex "Hox code" that is specific to the organ of origin 
and/or (possibly primarily) to the topographic location of the cells. Using degenerate 
PCR and cDNA cloning, Phinney and coworkers have previously derived a Hox 
gene expression profile of CFU-F cultured from hindlimb bone marrow (243). This 
profile almost completely overlaps with the hindlimb CFU-F profiles obtained by us, 
but lacks about 50% of the genes expressed by our hindlimb CFU-F colonies, and 
did not cluster with any of the CFU-F profiles (data not shown). The discrepancy 
between these profiles could have been caused by differences in culture conditions, 
but is more likely to be due to the fact that the profile obtained by Phinney et al. is 
dominated by a few abundantly expressed genes. 
 
 
Are CFU-F Hox codes inherent or induced? 
In keeping with previous data showing that the “identity” of CFU-F as reflected in 
their in vivo differentiation properties is maintained in vitro, topographic Hox codes 
appear to be an intrinsic property of CFU-F-derived fibroblasts. We found them to 
be independent of influences of hematopoietic cells in the cultures, and to be largely 
insensitive to culture under differentiation-inducing conditions. Whether Hox gene 
expression observed in CFU-F colonies reflects Hox codes pre-existent in the MSC 
from which they are derived, is an open question. Cell fate choice of MSC can be 
influenced by extrinsic cues, as evidenced by the finding that soluble signals 
released from injured skeletal muscle can instructively drive differentiation of MSC 
along the myogenic lineage in vitro (275). Thus, it is possible that MSC as they 
reside in different tissues are all equivalent and naïve, and acquire a specific identity 
only upon explantation and in vitro culture, which may mimic conditions of tissue 
injury. In preliminary transwell experiments to address this issue, we found no 
evidence for transfer of tissue-specific Hox codes by soluble factors from a 
heterologous CFU-F culture (data not shown). However, it is possible that this 
requires cell-to-cell contact, or higher concentrations of tissue-derived factors than 
can be attained in transwell cultures. Further experimentation will be necessary to 
conclusively address whether Hox codes are intrinsic or acquired, and whether they 
are maintained when MSC colonize a heterologous tissue, which may be relevant to 
transplantation of MSC in a clinical setting. The results described here provide a 
basis for addressing these questions. 
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Functions of Hox proteins in MSC 
Our findings align well with the canonical role of Hox proteins as master regulators 
of regional diversification and organ development in the embryo, and are compatible 
with the hypothesis that Hox codes are part of a "blueprint" required for MSC to 
carry out a program of regeneration that is appropriate for the tissue they reside in. It 
remains to be established which aspects of tissue regeneration are regulated by Hox 
proteins, and whether currently available assays are suitable for investigating their 
function. Given the circumstantial evidence linking Hox genes to adipogenic and 
osteogenic differentiation (20,60,104,123,182,257,287), an interesting question is 
whether differential expression of Hox genes underlies the different propensities for 
osteogenic and adipogenic differentiation exhibited by bone marrow-derived and 
non-bone marrow CFU-F cultures (see Figs. 2 and 4). As multiple genes may be 
involved, and complex interactions among Hox proteins may determine how the 
mRNA Hox code translates into cellular phenotypes (see refs. (158,192) for 
reviews), elucidating the functional importance of Hox genes expressed in MSC will 
be a difficult task, which will be the subject of future studies.  
 
 
Hox genes and the embryonic origin of MSC 
It is not known how MSC populations are established in different organs. They 
could originate locally, from organ primordia or in adult organs. Alternatively, they 
might be born elsewhere and later colonize different organs. The developmentally 
earliest putative precursors of MSC thus far described are the mesangioblasts, which 
can be isolated from the dorsal aorta of the E9 mouse embryo (209). Later in 
development, CFU-F can be found at sites of active hematopoiesis (206,324), 
suggestive of an ontogeny parallelling that of the hematopoietic stem cells. CFU-F 
have been detected in the embryonic circulation (38,206), supporting the idea that 
MSC migrate to distant sites. However, MSC might primarily colonize tissues as 
constituents of the wall of ingrowing blood vessels (27). Consistent with a 
perivascular origin, expression of smooth muscle markers is commonly detected in 
CFU-F cultures (see, e.g., Fig. 2), which suggests that MSC are pericyte-like cells 
(69). 
No lineage analyses pertaining directly to MSC have been done to our knowledge. 
However, results of fate mapping experiments in the chick suggest that vascular 
pericytes have heterogeneous origins. In the head, pericytes derive from the neural 
crest, which seeds the vascular primordia in a spatially coordinated manner (84). For 
the femoral bone marrow on the other hand, available data suggest that stromal 
pericytes originate in the femoral primordium, specifically the perichondrium (150). 
This is in agreement with histological observations made by others (reviewed by 
Simmons et al (292) ). If these findings can be extrapolated to the vertebrae, one 
might expect CFU-F colonies from vertebral bone marrow to have Hox codes 
corresponding to those of the prevertebrae. Yet, our data appear to be at variance 
with this. Different explanations are possible. It is conceivable that at the moment 
MSC are born, Hox gene expression domains in (pre)vertebrae or their precursors, 
are distinct from the prevertebral domains listed in Fig. 5, which were determined in 
E11.5-E12.5 embryos. Alternatively, MSC may originate from a tissue that is 
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patterned along the anteroposterior axis independently of the prevertebrae, and 
colonize the vertebrae in a coordinated fashion. 
Clearly, more work needs to be done to reconcile these different lines of evidence. 
Hox expression profiling of embryonic CFU-F and lineage tracing experiments in 
different systems will be helpful in further elucidating the relationships between 
patterning of the body plan and ontogeny of MSC. 
 
 
2.5 Materials and Methods 
CFU-F assay 
In all experiments FVB/N female mice (Harlan, The Netherlands) were used, which 
were sacrificed at eight weeks of age by cervical dislocation according to 
institutional guidelines. Sternum, femur and tibia (without joints) and humerus and 
ulna (combined, including the joints) were dissected out and attached muscle tissue 
was removed. Bone marrow was collected in Ca2+/Mg2+-free Hanks Balanced Salt 
Solution (HBSS, Gibco) supplemented with 10% fetal bovine serum (FBS, Summit 
Biotech, Fort Collins, CO, Lot# 50E42) by flushing and scraping with a hypodermic 
needle. Thymus and lung were cut into small pieces. Marrow and tissue fragments 
were dissociated by repeated pipetting, and the cell suspensions were filtered 
through a 70 μm nylon mesh filter (Cell-Strainer, Becton Dickinson). Nuclei were 
counted on a Beckman Coulter Z2 after cell lysis using Zap-oglobin II reagent 
(Beckman Coulter Inc.). Cells were pelleted at 200g for five minutes at room 
temperature and resuspended in DMEM (Cambrex, Belgium) supplemented with 
20% FBS, penicillin/streptomycin and 2×10-5 M ß-mercaptoethanol. Cells were 
plated in 6 cm polystyrene Falcon tissue culture dishes (Becton Dickinson) and 
cultured at 37oC in a humidified incubator in 5% CO2 in air. The medium was 
replaced after 5 days of culture. At day 13, CFU-F colonies with a diameter greater 
than 1 mm were counted. CFU-F colonies which after 13 days of culture had 
attained a diameter of approximately 3-5 mm in diameter and had a compact, 
circular morphology (representing the majority of colonies) were lysed with 0.8 ml 
of Trizol reagent (Invitrogen) using stainless steel cloning cylinders. 
 
 
CFU-F cultures from individual vertebrae 
Individual vertebrae were dissected free of surrounding tissue and crushed in HBSS 
with 10% FBS to collect the bone marrow. The marrow was processed as described 
above for the standard CFU-F assay, and all cells collected from one vertebra were 
plated in a 6 cm polystyrene Falcon dish. After 7 or 10 days, when colonies began to 
overlap, the entire dish was trypsinized using 0.25% trypsin (Gibco), and replated in 
a single well of a 6-well plate (Greiner). Upon reaching confluency, the 
hematopoietic cells were depleted as described below, and cells were lysed in 1 ml 
of Trizol. 
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Depletion of hematopoietic cells 
Dishes containing CFU-F colonies or monolayers were depleted of hematopoietic 
cells as described by Modderman et al. (211). In brief, cells were washed once with 
Ca2+/Mg2+-free HBSS, and incubated in HBSS containing 2 mM ATP (Sigma) for 5 
minutes at 37°C. Then potassium thiocyanate (Baker, the Netherlands) was added to 
a concentration of 1 mM. After a further 30 minutes at 37°C, an equal volume of 
cold HBSS containing 8 mM MgCl2 and 1% FBS was added to the cells. All liquid 
was subsequently removed and replaced with culture medium. This procedure was 
repeated after 24 hours, and cells were harvested 24 hours after the second 
treatment.  
 
 
Osteogenic and adipogenic differentiation 
Cell suspensions were generated from a total of four mice as described above for 
standard CFU-F assays, and the equivalent of 2 thymuses, 1.5 pairs of lungs, and 
bone marrow from 2 forelimbs, 1.5 sternums, or 1 femur was plated per 10 cm tissue 
culture dish (Greiner). The medium was replaced after 4 days and at day 11 the cells 
were lifted from the plate using 0.25% trypsin and seeded in seven 3.5 cm Falcon 
dishes, which yielded a near-confluent monolayer the next day, at which time the 
medium was replaced with differentiation medium. Cells were maintained in either 
osteogenic medium (DMEM with 10% FBS, 0.2 mM ascorbic acid, 1 mM β-
glycerol phosphate and 10-8 M dexamethasone, all from Sigma) or adipogenic 
medium (DMEM with 10% FBS, 5 μg/ml Insulin (Sigma) and 10-9 M 
dexamethasone) for 21 days with medium replacement three times per week. Cells 
were harvested before transfer to differentiation medium and after 21 days of 
differentiation, and duplicate plates were used for histochemical staining and RNA 
isolation. Intracytoplasmic lipids in adipocytes were visualized with Oil red O (259), 
and matrix mineralization was visualized using Alizarin Red (113). 
 
 
Analysis of gene expression 
All cell lysates were supplemented with 10 μg of bakers' yeast tRNA (Roche 
Diagnostics) as a carrier, and total RNA was extracted from the Trizol fraction 
according to the manufacturer’s protocol. The RNA was treated with 1 unit of 
DNase I (amplification grade, Invitrogen) for 30 minutes at 37oC. The enzyme was 
inactivated as recommended by the supplier, and the RNA was reverse-transcribed 
with oligo(dT) (Invitrogen) and SuperRT reverse transcriptase (SphaeroQ, the 
Netherlands) according to the supplier’s protocol in a reaction volume of 25 μl with 
RNase inhibitor (RNase-out, Invitrogen). All cDNAs were diluted with deionized 
water to a final volume of 200 μl, and either 0.2 μl (for the transwell experiment) or 
three μl (all other samples) was amplified in a 25 μl PCR reaction, using the primer 
pairs listed in Table S1 (supplementary data) and either SuperTaq (SphaeroQ, the 
Netherlands), Taq DNA Polymerase (Invitrogen) or Silverstar DNA polymerase 
(Eurogentec, Belgium). Reaction conditions optimized for each primer pair are 
available on request. Hprt1 was amplified for 30 cycles, all other targets for either 
35 cycles (for the differentiation experiment) or 40 cycles (all other samples). The 
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entire PCR reaction was run on ethidium bromide-stained agarose gel and the 
products visualized on a Typhoon 9200 Imager (Amersham). The images were 
processed with ImageQuant 5.2 (Molecular Dynamics), adjusting gamma and 
brightness for optimal visualization of PCR products. Using this procedure, a 
minimum of 1-2 ng of product was required to generate a visible band. 
Gene expression in cDNA pools consisting of equal amounts of cDNA from six to 
twenty-one colonies was analyzed in duplicate. Duplicate reactions yielded identical 
results except for Hoxd3 and Hoxd4 in a few cases, presumably because of the very 
low yields of PCR product for these two genes (data not shown). In these cases, 
PCR reactions were repeated in duplicate, and expression was ultimately scored as 
positive or negative according to the result of the majority of the reactions. The 
results of (-RT) control reactions were negative in all cases (data not shown). 
 
 
Hierarchical cluster analysis 
Gene expression data were represented in binary format based on the presence (1) or 
absence (0) of PCR product. The binary Hox gene expression profiles were 
subjected to agglomerative hierarchical clustering using the Treescape module of the 
OmniViz® software package. The similarity between the profiles was determined 
using the Tanimoto metric, and profiles were arranged in a dendrogram based on 
average linkage. 
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2.7 Supplementary data 
 
Table S1. Primers for RT-PCR analysis of gene expression 
 
Gene Acc. nr. Forward primer (5’-3’) Reverse primer (5’-3’) Ref.§ 
Hoxa1 NM_010449 CCAACTTCTGAGGCATCTGAC GATGTCGGCTGGAGAACAGT  
Hoxa2 NM_010451 GTGACTTCTCTTCCTCGTCT CTCCACGGGCCCTGCCTG  
Hoxa3 NM_010452 GTGCAGGAGGCTATCTGAAT GCAGTAAGGTCCGTGTAGGT  
Hoxa4 NM_008265 TGGATGAAGAAGATCCACGTGAGC TGTGAGTTTGTGCTTTCCCAGG  
Hoxa5 NM_010453 GCTGCACATTAGTCACGACAA GCAAAGGGCATGAGCTATTTCG  (333) 
Hoxa6 AF247663 CTGGTGCCCTTGTCTGCTCC GTGGCTCACAGAGCGCAGAG  
Hoxa7 BC036986 GCTGGAACTGGAGAAGGAAT GGGTTGTGGGTATCTACTGG  
Hoxa9 BC055059 CTTCGTGTGGCAGATCATTC CTCCATTACAATAAGCACTCACT  
Hoxa10 NM_008263 GAAGAAACGCTGCCCTTACACGAAG AACCCAGCCCATTCAGGACTTGAC  
Hoxa11 NM_010450 GTGTGGTCACTGGAGATTGG TGATGAGCACAGAGTGCAGG  
Hoxa13 NM_008264 ACGGCCAAATGTACTGCCC TCCCGTTCGAGTTCTTTCAAC (333) 
Hoxb1 NM_008266 ATCAGCCTACGACCTCCTCT AGCGTTGGAAGCCCAGTTA  
Hoxb2 NM_134032 TTCGCTGCAGACTCCTGTC CTGCAAGTCGATGGCACAG  
Hoxb3 NM_010458 GCTTCATGAACGCCTTACAC AAAGGTGATTGAGGCCGTAG  
Hoxb4 NM_010459 AGAACCCCCTGCATCCCA CCGAGCGGATCTTGGTGT  
Hoxb5 NM_008268 AGTATGAGTCTGGCTACAGC ATTGTAACACAGGACTGGGG  
Hoxb6 NM_008269 CGCCAGACCTACACACGCTA AGCACCTTCACTCGGCTGGC  
Hoxb7 NM_010460 TACAATCGCTACCTGACTCG CATCTGGAACCACAGTTCAC  
Hoxb8 NM_010461 AGTACGCAGACTGCAAGCTCG GCTCCTCCTGCTCGCATTTAC  (152) 
Hoxb9 NM_008270 GGCAAAGAGTAAAGATGACCAC GCTCGACTAGGGTCTCTTTC  
Hoxb13 NM_008267 CCAACGCTGATGCCAACTGT AGCAGAGAATCGTGGCGAGG  
Hoxc4 NM_013553 CGGCTTCAAGTACGACTACA AGAAGAAGGAGAGAGCTTGC  
Hoxc5 NM_175730 TGACTCCAAGCCCTTCCTGA CCAACACCTCTTTACCAAGCA  
Hoxc6 NM_010465 CTGACCGAGCGACAGATCAA GCAGACAAGCCAGGAAGAAG  
Hoxc8 NM_010466 ATCCTCCGCCAACACTAACAG CTCATTCCCTTCTTCTTCCACC (152) 
Hoxc9 AK078758 GGCAGCAAGCACAAAGAGGAGAA TTGCGCTGGGGAAGAGAACG (152) 
Hoxc10 NM_010462 ACCGCAGACTCCAGTCCAGA AGATGACGCTGGCTCAGGTG  
Hoxc11 XM_111600 CTACGTGCCTGAGTTCTCCA GTAGGCGTTGTCGAAGAAGC  
Hoxc12 NM_010463 GTTGGCTCGCGTGGAGGATA CGAATACGGCTTGCGCTTCT  
Hoxc13 NM_010464 CGTCAGGTCACCATCTGGTT  ACAAGCTGAGGCACAGGAAG   
Hoxd1 NM_010467 CTGGCCGGAATCTAGGAAGC CACGAAGAGGTAGGAGCGCA  
Hoxd3 AL928733 CTGCATTCTCCAGCCGGTCA GCGGCGCAACTGTAGTCCAC  
Hoxd4 J03770 CGGCCTACACCAGACAGCAA CCGCAGCTTCGCTCAACCTA  
Hoxd8 AK016033 CTGGTAGACGGAGAGGAAGA TAGGACAGCTCAAGGACTGC  
Hoxd9 NM_013555 CACTACGGGATTAAGCCTGAAACC TTTGGGTCAAGTTGCTGCTGC  
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Hoxd10 NM_013554 CCTATGGAATGCAAACCTGTGG ATATCCAGGGACAGGAACCTCG (34) 
Hoxd11 X71422 CAAGTACCAGATCCGCGAAC CTCAGGCTGTAGTGGTCGCT  
Hoxd12 X58849 GTCTGGTTCATTCGGCTCTC CAATTCCTTACGCTTCTGCC  
Hoxd13 NM_008275 GCCTGGCTACATCGACATGG GCCGCCGCTTGTCCTTGTTA  
Hprt1 NM_013556 CACAGGACTAGAACACCTGC GCTGGTGAAAAGGACCTCTC  
Tagln NM_011526   GCAAATTGGTGAACAGCCTG TGCTTCCCCTCCTGCAGTT (262) 
aggrecan NM_007424 CACGCTACACCCTGGACTTTG CCATCTCCTCAGCGAAGCAGT (335) 
Pparg2 NM_011146 ATGAATTCCTTAATGATGGGAGAAG GCCTGGGCGGTCTCCACTGAGA (332) 
adipsin NM_013459 ACTCCCTGTCCGCCCCTGAACC CGAGAGCCCCACGTAACCACACC
T  
(18) 
Runx2 NM_009820 GGCAGCACGCTATTAAATCCAAA TGACTGCCCCCACCCTCTTAG (309) 
Bsp L20232 CAAGCGTCACTGAAGCAGGTG CATGCCCCTTGTAGTAGCTGTATT (18) 
osteocalcin NM_031368 CAGACAAGTCCCACACAGCAGC AGAGCAGCCAAAGCCGAGC (18) 
Ptprc  NM_011210 ATGACTCATGTGCTCCAGC AGGTTTAGATACAGGCTCAG (63)  
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Table S2. Relationship between detection of Hox gene expression in P2 and 
the fraction of positive colonies in P2a. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 a, Indicated for each tissue are the number of colonies in P2 and the percentage of 
colonies in each pool that tested positive for expression of a given Hox gene. The 
background color of the cells reflects the outcome of the corresponding P2 PCRs 
Orange: P2 PCR positive, Blue: P2 PCR negative 
 
 
 pool size a1 a2 a3 a4 a5 a6 a7  a9 a10 a11  a13 
Lung  6 100 67 100 67 100 0 0  0 0 0  33 
Thymus  14 100 93 100 50 100 14 0  0 0 0  0 
Sternum 17 65 100 100 88 100 53 29  47 24 0  0 
Forelimb 18 67 94 94 83 100 61 33  100 100 50  11 
Femur 22 50 73 100 50 95 27 23  86 100 86  0 
Tibia  9 78 87 100 44 100 44 22  100 100 78  22 
               
 pool size b1 b2 b3 b4 b5 b6 b7 b8 b9    b13 
Lung  6 0 100 100 100 83 67 83 83 33    0 
Thymus  14 7 100 100 100 100 43 36 21 43    0 
Sternum 17 0 100 100 100 100 94 100 100 100    6 
Forelimb 18 0 100 100 100 44 11 22 11 17    0 
Femur 22 0 59 64 95 41 5 9 14 27    14 
Tibia  9 0 67 56 100 44 22 33 11 22    11 
               
 pool size    c4 c5 c6  c8 c9 c10 c11 c12 c13 
Lung  6    0 17 50  0 0 0 0 0 83 
Thymus  14    0 43 79  14 0 0 0 0 79 
Sternum 17    0 76 100  100 29 47 6 12 6 
Forelimb 18    6 56 89  89 6 6 0 0 17 
Femur 22    59 59 100  86 55 100 91 64 68 
Tibia  9    44 89 89  100 89 100 100 33 89 
               
 pool size d1  d3 d4    d8 d9 d10 d11 d12 d13 
Lung  6 100  0 17    0 0 0 0 0 0 
Thymus  14 50  50 50    86 36 0 0 0 0 
Sternum 17 12  6 29    53 41 6 0 0 0 
Forelimb 18 44  67 56    100 67 61 6 0 0 
Femur 22 86  36 54    82 45 23 9 0 0 
Tibia  9 89  0 0    44 33 0 0 0 0 
 44  
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3.1 Summary 
Mesenchymal Stem Cells (MSC) are multipotent cells that have been isolated from 
nearly every tissue or organ in the mammalian body. They can be analysed in vitro 
as CFU-F (colony forming unit-fibroblast), and upon expansion retain certain 
characteristics that reflect their tissue of origin. We have previously shown that 
CFU-F colonies derived from different locations in the adult mouse express 
characteristic combinations of Hox genes. However, it is unclear how these 
topographic expression patterns are established at the molecular level, and how these 
relate to the origin of MSC in the embryo. To begin to answer these questions, we 
have now investigated where the regulatory sequences responsible for driving Hox 
gene expression in CFU-F are located. The results of these studies suggest that most 
of these cis-acting elements are located within the confines of the Hox clusters. We 
also show that known region-specific enhancers can drive expression in CFU-F, but 
without any topographic specificity, and without any correlation to the expression in 
the corresponding cartilage primordia. These data corroborate the hypothesis that 
MSC in bone marrow do not originate locally from the same embryonic precursors 
as the bone they are found in, but colonize these from a distinct source. 
 
 
3.2 Introduction 
The vertebrate body is home to different kinds of multipotent stem cells that exhibit 
a limited differentiation potential, dedicated to a specific tissue or organ (183). 
Among these are the mesenchymal stem cells (MSC) that have been found in 
essentially all organs and tissues (65). MSC can be assayed in vitro, as colony 
forming units-fibroblast (CFU-F), based on their plastic adherence and 
clonogenicity. MSC expanded in culture can be induced to differentiate into several 
mesenchymal cell types including osteoblasts, chondrocytes, adipocytes and smooth 
muscle cells (reviewed by Prockop (253)). MSC from different organs have intrinsic 
differences in their proliferative capacity and differentiation efficiency (e.g., 
(65,94,96,98,136,273)). In asking how organ-specific properties of MSC are 
encoded, we have previously investigated the involvement of the Hox genes, which 
encode homeodomain transcription factors that are responsible for generating much 
of the regional diversity in the body. In vertebrates, 39 Hox genes have been 
identified that are organised in four paralogous clusters (A-D). During development, 
the clustered Hox genes are transcriptionally activated in a temporally and spatially 
coordinated manner, which correlates rather strictly with the linear order of the 
genes within their clusters. Genes located more 3’ in the clusters, relative to the 
common direction of transcription, start being expressed at earlier stages, and are 
expressed in more anterior regions, than successively more 5’ genes. These 
correlations have been termed temporal and spatial colinearity, respectively 
(reviewed by McGinnis and Krumlauf (204)). 
 
Studies about the regulation of colinearity showed that the underlying diverse and 
complex mechanisms are often highly conserved. The most intensively studied 
regulatory elements of colinear Hox gene expression are region-specific enhancer 
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elements, many of which have been identified in the vicinity of the genes, e.g. 
(15,29,49,201,256,304,327,350). Enhancers can be shared among several genes 
(88,103,160,162,285), and can also be located outside the clusters. The latter has for 
instance been found for Hox gene activation during mouse limb development in 
which several Hoxd genes are activated by an enhancer located more than 100 kb 
upstream of the cluster (300).  
Spatial colinearity of Hox gene expression is preserved to some degree in the adult 
animal (reviewed by Morgan (216)). Gene expression analysis of whole organs 
(308,343) or fibroblasts derived from different parts of the body display expression 
profiles that resemble the fetal colinear Hox patterning (266). Along the same lines, 
we have recently shown that Hox genes in CFU-F colonies derived from different 
locations of the adult mouse are also expressed in a somewhat colinear fashion. The 
combinations of Hox gene expression products are specific for the anatomical origin 
of the MSC, which we referred to as the topographic Hox code (2), analogous in 
concept to the vertebral Hox code as formulated by Kessel and Gruss (157).  
 
These findings raised two interconnected questions: Where do MSC originate, and 
how is Hox gene expression in these cells regulated? To begin to answer these 
questions, we now used transgenic mouse models to investigate where the regulatory 
sequences responsible for driving Hox gene expression in CFU-F are located, and 
used reporter constructs to track their tissue specificity of expression at fetal and 
adult stages.  
 
The results of these studies suggest that most of these cis-regulatory elements are 
located within the confines of the Hox clusters. We also show that small constructs 
containing previously defined region-specific enhancers, can drive expression in 
CFU-F colonies, but without any topographic specificity, and without any 
correlation to the expression in the corresponding cartilage primordia that is the 
hallmark of these region-specific enhancers. These data corroborate the hypothesis 
that MSC in bone marrow do not originate locally from the same embryonic 
precursors as the bone they are found in, but colonize these from a distinct source. 
 
 
3.3 Results 
HOXA transgenes reproduce regionally restricted and organ-specific Hoxa 
gene expression 
To capture as much of the complex regulatory interactions governing expression of 
the Hox loci as possible, we initiated our search for regulatory elements responsible 
for expression in CFU-F colonies by generating transgenic mice with two 
overlapping human HOXA cluster constructs covering the entire HOXA cluster and 
its flanking regions (Fig. 1A).  
Three independent lines were established for each construct. A rough estimate of 
transgene copy number was obtained for several of these, suggesting that one to 
three copies had integrated. In keeping with the observation that one or two copies 
of an intact human HOXD cluster are well tolerated in the mouse (301), all HOXA 
transgenic mice were viable and fertile and appeared healthy. They exhibited no 
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overt phenotypes except for line 170O19I-2, which occasionally developed 
elephant’s teeth. 
 
 
 
 
Figure 1. Overview of the transgenic constructs used in this study.  
A, the human PAC/BAC inserts aligned with the HOXA cluster. Arrows indicate the 
direction of transcription. B, the configuration of the murine Hoxb cluster around Hoxb8. 
Arrows indicate the direction of transcription and grey boxes represent coding region. 
The Hoxb8 reporter constructs are schematized below. The open arrowhead represents 
the LacZ gene followed by SV40 polyadenylation sequences. The position of the BH1100 
regulatory region is also indicated. The mutated Cdx binding sites in BH1100 in construct 
Hoxb8-III are indicated with X. The black arrowhead indicates the integration site of 
LacZ in Hoxb8lacZneo-. 
 
 
We asked whether the human HOXA constructs were able to reproduce the colinear, 
regionally restricted expression patterns of Hoxa genes in the embryo. We addressed 
this question by micro-dissection of embryos and RT-PCR. In order to distinguish 
between human and mouse HOX/Hox transcripts we designed species-specific 
primer sets. Human specific primer sets are shown in Table 1, mouse primer sets are 
shown in Table S1 from Chapter 2. Lines 881P4-1 and 170O19I-1 were analyzed in 
this manner. Within the limits of accuracy afforded by this method, transgenes in 
both lines were expressed with correct regional specificity and colinearity, and did 
not show any ectopic expression in the telencephalic region of the embryo (Fig. 2a 
and data not shown). 
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Table 1. Primers used in this study 
Gene Forward primer 5’-3’ Reverse Primer 5’-3’ 
HOXA1  CAGATTGGGTGCCAGCATAC GGAAGCCGGGTTTCTGAAGT 
HOXA2 CTTAGTTATTGACCTGGAGACTGG GTGCACAGGTTCAAGCCATAG 
HOXA3 * CACAGTGGCCAAACAAATCTTCC CTGATCCTTTTTGTACTCATGCGG 
HOXA4 AGCAGGTCTTGGAGCTGGAG CACACCTGGCAGCCTTGTT 
HOXA6 GGCAAAGGCGGGCGAGTAG CGAGGTCGGGGAGCTCAG 
HOXA7 CGCTGCATGGCGCGGCTGAG GCAGCAGTGGCGGCGGCAGA 
HOXA9 # CCCAGCAGCCAACTGGCTTCATGCGC CACTCGTCTTTTGCTCGGTCTTTG 
HOXA10 CTGATGAATCTCCAGGCGACG TGACACTTAGGACAATATCTATCTC 
HOXA11 CATTGGATTCTGAGAGCTGTGC AGTCCACTCTGTGTCGAGGCTT 
Venus TGGATAACCGTATTACCGCCATGC CGCTTACAATTTACGCCTTAAGAT 
LacZ ACTTGCTGATGCGGTGCTGA GCGGCTGATGTTGAACTGGA 
* (134)    # (280)     
 
Adult organs and tissues have distinct Hox gene expression profiles when analyzed 
at a gross level (reveiwed by Morgan (216)). We used species-specific primers to 
compare expression of the human and murine Hoxa10 and Hoxa2 paralogs in several 
organs from adult mice of lines 881P4-1 and 170O19I-1. Expression of the 
transgenes agreed rather well with that of their murine paralogs, (Fig. 2b), 
suggesting that both constructs can also reproduce expression at adult stages with 
reasonable fidelity. 
We also investigated whether the human transgenes are expressed in various 
hematopoietic cell populations sorted from the bone marrow, including the 
CD45+Lin- population that is enriched in progenitor cells and was previously shown 
to exhibit the most pronounced expression of Hox genes. We failed to detect 
expression of any HOXA transgene in hematopoietic cells, in contrast to some of 
their murine paralogs (see Chapter 4). This suggests that the enhancers responsible 
for the hematopoietic lineage are located outside the genomic region covered by 
RP11-881P4 and RP1-170O19 
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Figure 2. Region- and organ-specific expression of HOXA transgenes. 
(A), expression of selected Hox genes in axial structures of E9.5 embryos. The panel on 
the left shows regions 1-6 in which the anteroposterior axis of the embryo was subdivide; 
region 2 extends down to the first somit, regions 3-5 are sections of the axis comprising 7 
somites each. The panel on the right shows expression of the Hoxa paralogue group 1, 
6, and 10 genes in regions 1-6 of a line 881P4-1 transgenic embryo (t) and wild type 
littermate (w). (B), expression of Hoxa2 and Hoxa10 and their human paralogues in 
various organs of line 881P4-1 adult mice. Expression of the endogenous β-actin gene is 
shown as internal control for cDNA quality. Sp.cord, spinal cord. (C), expression of 
Hoxa10 and HOXA10 in organs of line 170O19I-1. 
 
 
HOXA transgenes are expressed in CFU-F colonies  
We have shown that topographic Hox codes in CFU-F colonies are heterogeneous 
but highly characteristic for their origin. In two independent experiments, this 
topographic specificity was exhibited correctly by cDNA pools comprising six or 
more colonies (Chapter 2). Expression of HOXA  transgenes was therefore analyzed 
in cDNA pools of ten CFU-F colonies derived from several tissues of RP1-170O19I 
and RP11-881P4 transgenic mouse lines using human-specific primer sets. 
Expression of HOXA5 and HOXA13 was not determined because we were unable to 
design human-specific primers that yielded a correct product. HOXA transgene 
expression was compared to the endogenous Hox profiles of CFU-F cDNA pools 
previously derived for wild type mice (Chapter 2). The results are summarized in 
Figure 3. The HOX expression profiles of equivalent CFU-F colonies of human 
origin are unknown and could conceivably be different from the murine profiles. 
However, despite several differences, some of which were consistently observed in 
independent lines, the expression of human and murine paralogs in CFU-F colonies 
from the transgenic lines agreed remarkably well. This indicates that the regulatory 
elements responsible for topographic specificity of expression in CFU-F colonies are 
located within the confines of the HOXA cluster and its immediate environs. 
Moreover, the fact that the genes in the region of overlap between RP11-881P4 and 
RP1-170O19 were expressed with largely correct specificity in both 881P4 and 
170O19I lines, suggests that at least some of these regulatory elements might be 
relatively close to the genes they activate. 
 
 
Is expression in CFU-F regulated through region-specific enhancers? 
Having established that cis-acting sequences responsible for expression of Hox 
genes in CFU-F colonies appear to act locally, we asked whether these elements 
might coincide or overlap with region-specific enhancers known to be active during 
development. 
To answer this question, we decided to investigate the Hoxb8 gene, since (i) it is 
robustly expressed in all CFU-F colonies from sternebral bone marrow but rarely in 
those from femoral bone marrow (see Chapter 2), and (ii) several region-specific 
enhancers have been identified in the vicinity of Hoxb8, some of which have been 
analyzed in detail (49,50,327). 
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Figure 3. HOXA gene expression profiles of BAC/PAC trangenic animals. 
Expression of HOXA genes analyzed in cDNA pools derived from several tissues of RP1-
170O19I and RP11-881P4 transgenic mouse lines. HOXA transgene expression was 
compared to the endogenous Hox profiles of CFU-F cDNA pools previously derived for 
wild type mice (wt). RT-PCR results for three independent lines for each of the constructs 
is indicated by the shading, as explained in the legend. 
 
 
We used previously described reporter constructs, in which the LacZ reporter gene 
is inserted as a translational fusion close to the N-terminus of Hoxb8, and followed 
by SV40 polyadenylation sequences (see Fig. 1B). These fusion transcripts thus lack 
the 3’-untranslated region (3’-UTR) of Hoxb8, which has been demonstrated to be a 
target for micro RNA-mediated mRNA degradation by miR-196 (132,344). This 
mechanism appears to prevent ectopic activation of Hoxb8 by exogenous retinoic 
acid in the developing hindlimb (132), and conceivably could also be responsible for 
the lack of Hoxb8 expression in CFU-F colonies from femoral bone marrow. 
Therefore, we first verified that the lacZ reporter gene in Hoxb8lacZneo- knock in 
mice, which is fused slightly more downstream in exon 1 and also lacks the Hoxb8 
3’-UTR  ((323); see fig. 1B), correctly reproduces expression of Hoxb8 in CFU-F 
colonies. This appeared to be the case (Fig. 4A). However, none of the colonies 
showed ß-galactosidase expression detectable by Xgal staining (data not shown). 
  
Next, we investigated a transgenic mouse line, L048, that harbours a randomly 
integrated Hoxb8 reporter construct containing 11 Kb of genomic sequence 
upstream of the gene (construct 1 of ref. (50), here called Hoxb8-I, see Fig. 1B). 
Several region-specific regulatory elements have been mapped within this 11 Kb of 
upstream sequence (50). CFU-F colonies from sternebral bone marrow of L048 mice 
all expressed lacZ, including one colony that did not express Hoxb8 (Fig. 4A). In 
addition, lacZ was expressed in a significant fraction of CFU-F colonies from 
femoral bone marrow that did not express Hoxb8 (Fig. 4A). To verify that this 
ectopic expression in femoral bone marrow CFU-F was not due to influences from 
the integration site in this particular transgenic line, we generated more transgenic 
mice with construct Hoxb8-I.  
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Figure 4. Expression of Hoxb8 and lacZ in CFU-F colonies from Hoxb8 reporter mice. 
(A), expression in individual CFU-F colonies from sternebral and femoral bone marrow of 
wild type, Hoxb8lacZneo-, and line L048 mice. (B), expression of Hoxb8 and lacZ in pools 
of 10 colonies from femoral (f) and sternebral (s) bone marrow of F0 animals carrying 
Hoxb8 reporter constructs (see also Table 2). (C), expression of Hoxb8 and lacZ in 
individual CFU-F colonies for three of the F0 mice. 
Hoxb8-I Hoxb8-II Hoxb8-III 
C 
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The F0 animals (see Table 2) were sacrificed for analysis after siring a litter of 
embryos to determine the pattern of expression in the embryo. F1 embryos from one 
of these founders, Hoxb8-I-4, showed ß-galactosidase activity in a regionally 
restricted pattern previously determined to be characteristic of construct Hoxb8-I 
(Fig. 5C; see ref. (50)). Analysis of the founder animal also revealed expression of 
lacZ in CFU-F colonies from both sternebral and femoral bone marrow (Fig. 4B), 
suggesting that this is an intrinsic property of construct Hoxb8-I. The embryonic 
expression pattern of founder Hoxb8-I-1 could not be determined, and founders 
Hoxb8-I-2 and Hoxb8-I-3 yielded embryos with expression patterns that would be 
classified as “ectopic” (50), and presumably reflect the influence of enhancers 
located close to the integration site. Surprisingly, all three of these founders robustly 
expressed lacZ in CFU-F from both sternum and femur.  
 
 
Table 2. Hoxb8 transgenic founders and their progeny  
Founder Sex # of 
embryos 
age (E) # 
transgenic 
# of 
Xgal(+) 
panel 
in Fig. 5 
Hoxb8-I-1 F 12 11.5 0 0  
Hoxb8-I-2 F 3 11.5 1 1 A 
Hoxb8-I-3 F 8 11.5 4 4 B 
Hoxb8-I-4 F 9 11.5 3 3 C 
Hoxb8-II-1 F 11 11.5 0 0  
Hoxb8-II-2 F 11 11.5 0 0  
Hoxb8-II-3 F 12 12.5 9 9 D 
10 12.5 8 8 Hoxb8-II-4 M 
9 11.5 4 4 
E 
7 11.5 3 3 Hoxb8-II-5 M 
9 11.5 3 3 
F 
Hoxb8-II-6 F 8 11.5 5 5 G 
Hoxb8-II-7 F 7 11.5 4 0  
Hoxb8-III-1 F 10 11.5 9 9 H 
Hoxb8-III-2 F 9 11.5 7 7 I 
Hoxb8-III-3 F 8 11.5 5 0  
 
Overview of F0 founder animals carrying constructs Hoxb8-I, Hoxb8-II, and Hoxb8-III, and 
the F1 embryos obtained from them in one or two litters. Listed are the total number of 
embryos in each litter, and the number of transgenic and Xgal-positive embryos among 
these. Representative expression patterns are shown in Fig. 5. 
 
 
To further narrow down the sequences responsible for expression in CFU-F, we then 
tested construct Hoxb8-II (construct 7 of ref. (50)), containing a 1.1 Kb region-
specific enhancer element, BH1100, fused to the Hoxb8 promoter region. 
This BH1100 element is also present in construct 1, and is responsible for 
establishment of the anterior expression boundary. The Hoxb8 promoter region 
alone is unable to direct regionally restricted expression in the embryo (50). Founder 
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Hoxb8-II-5 yielded embryos that showed a ß-galactosidase expression pattern 
characteristic of this construct (50), including a Hox-like expression domain in 
neurectodem and mesoderm, and ectopic expression in peripheral cranial ganglia 
(Fig. 5F).  From Hoxb8-II-5 a transgenic mouse line was established (L-II-5). 
Founder Hoxb8-II-4 yielded embryos that in addition to the pattern seen for Hoxb8-
II-5, showed more extensive ectopic expression in cranial ganglia and nerves as well 
as the spinal ganglia (Fig. 5E). RT-PCR analysis of cDNA pools of ten CFU-F 
colonies revealed that both founder Hoxb8-II-4 and an F1 animal from Hoxb8-II-5 
expressed lacZ in CFU-F colonies from femur as well as sternum (Fig. 4B). 
Analysis of individual colonies from the F1 animal from L-II-5 showed that in fact, 
all colonies from femur expressed lacZ, irrespective of whether they expressed 
Hoxb8 (Fig. 4C). From these analyses we conclude that ectopic expression of lacZ 
in CFU-F colonies from femoral bone marrow is an intrinsic property of construct 
Hoxb8-II. Like was the case for the Hoxb8lacZneo- mice, for all of the transgenic 
lines or founders described above, expression of the lacZ reporter in CFU-F colonies 
at the protein level was undetectable by Xgal staining (data not shown). However, in 
contrast to the L-II-5 F1 animal, offspring from a later generation showed readily 
detectable ß-galactosidase expression in a small subset (~1-5%) of CFU-F colonies 
from both sternebral and femoral bone marrow (Fig. 6A-C).  
 
 
         
A. Hoxb8-I-2   B. Hoxb8-I-3   C. Hoxb8-I-4   D. Hoxb8-II-3  E.Hoxb8-II-4  F. Hoxb8-II-5       
 
      
G. Hoxb8-II-6  H. Hoxb8-III-1 I. Hoxb8-III-1 J. Hoxb8lacZneo-  K. L048  L. Hoxb8-II M. Hoxb8-III 
 
Figure 5. ß-galactosidase expression in embryos carrying Hoxb8 reporter constructs.  
F1 embryos from F0 founders carrying Hoxb8-I (A-C), Hoxb8-II (D-G) and Hoxb8-III (H, I). 
See table 2 for details.  (J), E11.5 Hoxb8lacZneo- embryo, reproduced from ref. (323), 
showing the endogenous Hoxb8 expression pattern. (K), E12.5 line L048 embryo. (L), 
E11.5 Hoxb8-II embryo, reproduced from ref. (49). (M), E11.5 Hoxb8-III embryo, 
reproduced from ref. (49). 
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Developmental expression 
We wondered if we could detect a relationship between Hoxb8 expression in 
cartilage primordia and in CFU-F colonies. We investigated reporter gene 
expression at different stages of development and in the adult bone marrow of 
Hoxb8lacZneo-, line L048 and L-II-5 mice. Expression of ß-galactosidase in skeletal 
precursors in E11.5, Hoxb8lacZneo- embryos appears to be restricted to the 
prevertebral condensations ((323), Fig. 5J), and this fits with the complete lack of 
expression in sternum and limbs at E16.5 (Fig. 6D, E). Constructs Hoxb8-I and 
Hoxb8-II on the other hand, consistently drive expression in the ventrolateral body 
wall and in part of the mesenchyme in the hindlimb bud at E11.5/E12.5 ((50), Fig. 
5K, L). In keeping with this early expression, at late foetal stages, both lines L048 
and L-II-5 show robust ß-galactosidase expression in the ventral rib cage (Fig. 6F 
and I, respectively), including the cartilage of the sternum and its perichondrium, the 
ribs, and the surrounding muscles (Fig. 6J). In the hind limbs, expression in these 
two lines is qualitatively different. Line L048 foetuses exhibit strong expression in 
the knee area but no detectable expression in the femur (Fig. 6G, compare to wild 
type shown in Fig. 6H). Limbs of line L-II-5 foetuses show a more elaborate pattern 
of expression, which includes Schwann cells of the peripheral nerves (in both fore- 
and hind limbs, see Fig. 6K, L; data not shown), part of the dermis (Fig. 6L), and 
expression in a proximal region comprising the hip joint, the head of the femur and 
surrounding tissues (Fig. 6M). In agreement with the expression at foetal stages, 
adult Hoxb8lacZneo- mice did not show any ß-galactosidase expression in either the 
femur (not shown) or the sternum (Fig. 6O) that extended beyond the endogenous 
background activity (see wild type sternum, Fig. 6N). Line L048 adults showed 
expression in the cartilaginous parts of the sternebrae and in their periosteum, but 
not within the bone marrow cavity (Fig. 6P; data not shown). No expression was 
observed in the femoral bone marrow (data not shown). L-II-5 on the other hand, 
exhibited more pronounced expression in the sternebral bone marrow cavity (Fig. 
6Q). This includes expression in blood vessels penetrating the bone (Fig. 6R). 
Interestingly, Xgal-stained blood vessels were also observed within the femoral 
bone marrow (Fig. 6S). 
 
To further investigate the connection between expression domains in the embryo 
and expression in CFU-F in the adult, we generated F0 mice with construct Hoxb8-
III, in which four Cdx binding sites within BH1100 have been inactivated. These 
mutations completely abolish the ability of this enhancer to drive regionally 
restricted expression in the embryo (49). Two founders, Hoxb8-III-1 and Hoxb8-III-
2, yielded F1 embryos with predominantly but not exclusively neural expression 
extending into the brain (Fig. 5H, I). This expression pattern is similar, but not 
identical to what was previously determined to be characteristic of this construct 
((49); see Fig. 4M). Both founders, as well as a third founder (Hoxb8-III-3), that did 
not show expression in F1 embryos, expressed lacZ mRNA in CFU-F colonies from 
sternum and femur (Fig. 4B, C). We can, however not exclude that this expression 
was the result of enhancers near the integration site, activating the Hoxb8 promoter 
at later stages. 
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Taken together, these data show that (i) expression in CFU-F colonies that is readily 
detectable at the mRNA level may not result in detectable levels of ß-galactosidase 
activity, and (ii) expression in CFU-F colonies is not correlated with expression in 
the primordia of the bones in which they are located. This agrees with our previous 
finding that Hox codes in CFU-F derived from the bone marrow of individual 
vertebrae are distinct from the vertebral Hox codes established during 
embryogenesis (see Chapter 2).  
 
 
 
 
 
Figure 6 (next page). Analysis of ß-galactosidase expression in situ and in CFU-F 
colonies. 
(A), Part of a 6 cm dish with CFU-F colonies from femoral bone marrow of line L-II-5 
carrying construct Hoxb8-II, showing one Xgal-positive colony (arrow). (B), close up view 
of Xgal-positive colony shown in A. (C), high magnification view of blue cells showing 
fibroblastoid morphology. (D, E), ventral rib cage (D, anterior to the top), forelimb (E, 
top) and hindlimb (E, bottom) dissected from an E16.5 heterozygous Hoxb8lacZneo- 
embryo and stained with Xgal. (F), ventral rib cage of an E18.5 fetus of line L048, 
carrying construct Hoxb8-I, showing regionally restricted ß-galactosidase expression in 
part of the ribs (numbered) and sternum (arrowheads). 
(G, H), proximal hindlimbs of a line L048 transgenic fetus and a non-transgenic 
littermate, respectively, with the femur dissected free of overlying muscles. Note Xgal 
staining over the knee area in G, but lack of expression in the femur (f; compare to 
femur in H). (I), ventral rib cage of an E18.5 fetus of line L-II-5, anterior to top, showing 
regionally restricted ß-galactosidase expression in ribs (numbered) and sternum 
(arrowheads). (J), frontal section through the rib cage similar to the one shown in I, 
showing the anterior boundary of expression in the cartilage primordium of the sternum 
(arrowhead), and expression in the perichondrium (pc), the ribs (numbered), and 
intercostal muscles (mu). (K, L), dissected forelimb and hindlimb, respectively, of an 
E18.5 fetus of line L-II-5, showing expression in peripheral nerves (pn). In the hindlimb, 
there is also expression in part of the dermis (d) and in the proximal part of the limb 
(arrowhead). (M), section through the proximal hindlimb of an E18.5 fetus of line L-II-5, 
showing ß-galactosidase expression in the hip joint including the femoral head (f) and 
the overlying tissues. (N, O, P, Q), sternums of adult wild type (N), Hoxb8lacZneo- (O), 
line L048 (P), and line L-II-5 (Q) mice, cut longitudinally and stained with Xgal. Note 
weak endogenous galactosidase activity in cells near the anterior and posterior ends of 
the sternebrae in N (open arrowheads), and similar expression in O, but lack of 
expression in the bone marrow in N, O, and P. In P and Q, stronger expression of ß-
galactosidase is detected in and along the cartilage and bone of the sternebrae, the 
white arrowhead in Q indicating the anterior limit of expression. In the line L-II-5 sternum 
(Q) there is also expression within the bone marrow cavity (black arrow). (R, S), higher 
magnification of the sternebral and femoral marrow cavities (bm), respectively, of a 
line L-II-5 adult, showing prominent Xgal staining along blood vessels (white arrows). The 
scale bar in A represents 5 mm, in C 0.1 mm, those in other panels 1 mm. 
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3.4 Discussion 
Large transgenes reproduce topographic specificity of Hox gene expression 
in CFU-F 
Hox codes in CFU-F colonies from different locations display some spatial 
colinearity in that those derived from more posterior locations tend to express 
increasingly more 5’ genes than those from more anterior locations. This colinearity 
is more apparent in CFU-F colonies from vertebral bone marrow, although there are 
clearly more exceptions in the expression pattern than have been observed for the 
canonical regional expression domains in the embryo (Chapter 2). These 
observations strongly suggested that Hox gene expression in CFU-F is driven by 
region-specific regulatory elements. Here, we have demonstrated that the in vivo 
activity and specificity of such putative elements are contained within genomic 
constructs comprising parts of the HOXA cluster. This data also suggested that these 
elements might act relatively locally, on genes within their immediate environment. 
For each of the two genomic HOXA transgenes, some differences were observed 
between independent transgenic lines. Some of these may be accidental, because 
CFU-F colonies are sampled from a heterogeneous population. We have previously 
shown that pools of CFU-F colonies in independent experiments may occasionally 
show differences in expression of the endogenous Hox genes as well (see Chapter 
2). Overall, the human transgenes reproduced expression of the endogenous Hoxa 
genes rather faithfully, but relatively consistent differences were apparent for 
HOXA11 and HOXA4, which are located near the end of constructs RP11-881P4 
and RP1-170O19, respectively. This may be due to these genes being more exposed 
to influences from the host genome at the site of integration. However, comparing 
expression of HOXA4 in CFU-F colonies from thymus, lung, and femoral bone 
marrow reveals consistent differences between RP11-881P4 and RP1-170O19I 
lines, which are not readily explained by integration site effects. These differences 
might provide clues to the location of some the regulatory elements involved. 
HOXA11 on the other hand was expressed in CFU-F from sternebral bone marrow 
in five of the six lines, contrasting with the consistent absence of endogenous 
Hoxa11 expression in sternebral CFU-F colonies.  This might reflect a genuine 
difference in regulation of the human and murine paralogues in CFU-F from the 
sternum. Expression profiling of CFU-F colonies from human sternebral bone 
marrow could clarify this issue.  
 
Discrepancy between mRNA and protein expression 
When we investigated the involvement of previously identified embryonic region-
specific enhancer elements in driving expression of Hoxb8 in CFU-F colonies, a 
rather different picture emerged. First of all, a lacZ reporter integrated in the 
endogenous Hoxb8 coding region faithfully reproduced differential expression of 
Hoxb8 in CFU-F colonies from sternebral versus femoral bone marrow at the 
mRNA level, but did not yield detectable levels of ß-galactosidase expression in 
these cells. The same observation was made for the vast majority of transgenic mice 
carrying randomly integrated Hoxb8 reporter constructs. This might indicate that 
mRNA expression levels are too low to allow for histochemical detection of the 
protein, although our non-quantitative RT-PCR analyses did not suggest a difference 
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in expression levels in CFU-F colonies versus whole embryos. Conceivably, it could 
also reflect translational repression of Hoxb8 expression in CFU-F. As an exception, 
some of the CFU-F colonies from L-II-5 showed robust ß-galactosidase activity, 
suggesting that translational repression, if it exists, is not absolute. More detailed 
experiments, including quantitative analysis of mRNA expression levels in CFU-F 
colonies from L-II-5 mice, and testing the influence of the 5'-UTR on the efficiency 
of mRNA translation, might help resolve this issue. 
 
 
Small region-specific enhancers do not exhibit specificity in CFU-F 
Reporter constructs containing variable parts of the Hoxb8 upstream region showed 
strongly decreased specificity of expression in CFU-F colonies from sternebral 
versus femoral bone marrow. However, the lack of specificity of expression in CFU-
F colonies derived from adult mice bearing construct Hoxb8-I, contrasts sharply 
with the differential expression in sternum versus femur driven by this construct 
prenatally. This discongruence is in agreement with the analysis of constructs 
Hoxb8-II and Hoxb8-III that showed a predominant lack of correlation between 
topographic LacZ expression in the embryo and in CFU-F in the adult. This 
observation is consistent with our hypothesis that CFU-F do not originate locally 
from the prevertebral condensations, which we based on the CFU-F Hox codes from 
vertebral bone marrow (see Chapter 2). Distinct regulatory elements could be 
responsible for expression in CFU-F and/or their actual precursor cells. 
 
We have observed expression in some blood vessels within the bone marrow 
cavities in sternum and femur of line L-II-5 adults. Mounting evidence suggests that 
MSC are pericyte-like cells e.g. (61,64,149,288,353). Interestingly, Le Douarin and 
coworkers have suggested that pericytes in the femoral bone marrow are derived 
from the perichondrium of the femoral primordium (150). Further developmental 
analyses, and prospective sorting based on ß-galactosidase expression using line L-
II-5 may be helpful in elucidating the developmental origin of al least the small 
subset of CFU-F that detectably express ß-galactosidase. Furthermore, it will be 
interesting to isolate pericytes from different tissues and determine if they have Hox 
codes that resemble those of CFU-F from the same location.  
 
 
Are CFU-F Hox codes functionally relevant? 
The faithful reproduction of CFU-F Hox codes by large HOXA transgenes contrasts 
sharply with the lack of specificity of small Hoxb constructs. Also we observed a 
lack of correlation between topographic LacZ expression in the embryo and in CFU-
F in the adult. These observations may be indicative of the existence of specific 
regulatory elements dedicated to mesenchymal stem cells or their precursors, 
distinct from the embryonic region-specific enhancers present in the Hoxb8 reporter 
constructs used in this study. Another explanation may be found in the fact that 
establishment of CFU-F cultures involves activation of previously quiescent cells 
(94). It is possible that Hox codes in CFU-F colonies reflect a non-physiological 
activation of transcription due to the environmental stress involved with explantation 
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and in vitro culture. A similar effect has been observed upon activation of NK cells 
and T cells in vitro, which caused coordinated transcriptional activation of the Hoxb 
cluster (41,258). Induction of Hox gene expression in this manner could conceivably 
be modulated by epigenetic marks retained from an earlier phase of expression, i.e., 
in a CFU-F precursor cell. It is reasonable to assume that large constructs, 
containing multiple polycomb response elements necessary for maintenance of 
silencing mediated by Polycomb-group proteins (226), could better preserve 
repressive chromatin marks than small transgenes. This might explain the 
differences in specificity observed between our HOXA and Hoxb constructs. 
Even if non-physiological, the induction of Hox gene expression in CFU-F-derived 
cells may have phenotypic consequences. Although the lack of ß-galactosidase 
activity in CFU-F colonies from Hoxb8lacZneo- mice suggests that functional 
protein expression of at least this one gene is quite low or absent, it is unknown 
whether this can be extrapolated to other Hox genes. Furthermore, several Hox genes 
have been shown to have redundant or overlapping functions (158,192), and 
expression of multiple Hox genes with overlapping functions might have additive 
effects e.g. (52,53,66,100,130). Functional assays involving deletion or over 
expression of Hox genes will be required to address this issue. 
 
 
3.5 Materials and methods 
DNA Constructs 
Human genomic BAC and PAC clones were obtained from the BACPAC Resources 
Center (http://bacpac.chori.org) at the Children’s Hospital Oakland Research 
Institute (Oakland, CA). Clone RP1-170O19 is derived from the RPCI-1 library 
cloned in pCYPAC2 (138), and contains an insert of 129 Kb (acc. nr. AC004080). It 
extends from ~10 Kb downstream of the EVX1 coding sequence to the first exon of 
HOXA3 isoform-a transcript 2, ~2 Kb downstream of the HOXA4 polyA sequence. 
 
Clones RP11-881P4 and RP11-884O23 are derived from the RPCI-11 library, 
cloned in pBACe3.6 (229). Both clones were identified by hybridization of RPCI-11 
high-density filters with a HOXA4 probe (data not shown). The ends of the RP11-
881P4 insert were sequenced with SP6 and T7 primers, and the sequences were 
aligned with the human chromosome 7 sequence BL000002.1 (NCBI) using 
BLAST. From this analysis the insert was inferred to be 201kb in size and to extend 
from BL000002.1 (GI:30089982) basepair no. 26734363 (SP6 end) to 26935695 
(T7). These positions correspond to basepair 69097 of AC073472 (Sp6), 140kb 
downstream of HOXA1, and to basepair 61492 of AC004080 (T7), about 3kb 
upstream of the first exon of HOXA11 (Figure 1). 
 
The integrity and stability of the clones were verified by PCR with HOXA gene-
specific primers listed in Table 1, and by restriction enzyme digestion. Restriction 
fragments were separated with standard agarose gel electrophoresis and pulsed field 
gel electrophoresis (PFGE) using a Rotophor system (Biometra). For each clone, 
several individual colonies derived from the initial stab culture were analysed, and 
one that conformed to the published sequence by restriction analysis was used for 
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generating transgenic animals. The BamHI restriction pattern of RP1-170O19 was 
consistent with AC004080 (data not shown). AscI and KpnI digests of RP11-881P4 
were consistent with BL000002.1 except for the absence of a KpnI site predicted to 
be at 20107 bp from the SP6 end, resulting in a 8.5 Kb KpnI fragment replacing the 
predicted fragments of 6.9 and 1.6kb. This site was also missing in a partially 
overlapping clone, RP11-884O23 (data not shown), and might indicate a 
polymorphism. Based on restriction analyses, both RP1-170O19 and RP11-881P4 
were stable over multiple DNA isolations. 
 
RP1-170O19 does not contain a unique cutting site in the vector sequence that 
would allow linearisation. We therefore generated the retrofitting vector pRetroES-I 
by inserting a NotI;I-SceI;SalI;SacI adaptor into the SacI and NotI sites of pRetroES  
(gift of Dr. Ursula Storb) (334) The adapter was created by annealing oligos 5’-
GGCCGCTAGGGATAACAGGGTAATGTCGACGAGCT-3’ and 5’-
CGTCGACATTACCCTGTTATCCCTAGC-3’ (gift of Dr. Ali Imam). 
pRetroES-I was then retrofitted into the loxP site of RP1-170O19 using published 
procedures ((334); see appendix), yielding RP1-170O19I. 
 
Hoxb8 reporter constructs Hoxb8-I, Hoxb8-II and Hoxb8-III have been previously 
published, and correspond to constructs 1 and 7 of ref.(50), and construct 16m of 
ref.(49), respectively (see also Figure 1b). 
 
 
Transgenic mouse lines 
Hoxb8lacZneo- knock in mice (323) and the L048 transgenic mouse line carrying 
construct Hoxb8-I (50) were used after at least 10 generations of backcrossing to 
C57BL/6 x CBA F1 mice. 
  
For the generation of transgenic mice, BAC and PAC constructs were isolated from 
large-scale bacterial cultures by alkaline lysis followed by caesium chloride gradient 
equilibrium density centrifugation. RP11-881P4 and RP1-170O19I were linearized 
with PI-SceI and I-SceI (New England Biolabs), respectively, and the enzymes were 
inactivated according to the manufacturer’s instructions. The digested DNA was 
separated by PFGE, and the linear form was excised from the gel, electro-eluted, 
dialyzed against micro injection buffer (8 mM Tris-HCl pH7.5 and 0.1 mM EDTA), 
and concentrated by vacuum dialysis.  
 
The inserts of constructs Hoxb8-I, Hoxb8-II and Hoxb8-III were separated from 
vector sequences, purified from a standard agarose gel by electro-elution, and 
dialyzed against micro injection buffer. 
 
Purified DNA fragments were micro injected into the pronuclei of 1-cell embryos of 
the FVB/N strain (Harlan), which were transferred to C57BL/6 x CBA F1 pseudo 
pregnant females. Mice were routinely genotyped by PCR. Transgenic lines carrying 
RP11-881P4 or RP1-170O19I were maintained by brother-sister mating. Integration 
of the constructs was verified by PCR with human-specific HOXA primers (see 
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Table 1). A rough estimate of transgene copy numbers was obtained by Southern 
blot analysis, comparing the signal of a human HOXA2 probe to that of a probe of 
about equal size against the endogenous Shh gene.  
 
 
Hoxb8 founder analysis 
Transgenic founder animals were mated with wild-type mice and females sacrificed 
between 11.5 and 12.5 days after a vaginal plug was detected. Male founders were 
sacrificed after producing transgenic offspring. The animals were killed by cervical 
dislocation according to institutional guidelines. The embryo’s were dissected from 
the uterus and stained for ß-galactosidase activity using standard procedures. The 
yolk sac was used for genotyping by PCR for the LacZ gene with primers described 
in Table 1.  
 
 
CFU-F 
CFU-F assays were performed as described in Chapter 2 (2), except that for the 
L048 and Hoxb8lacZneo- mice DMEM was replaced by IMDM (Gibco # 041-
90898M).   
RNA isolation and PCR Analysis  
Mouse organs were dissected and washed in PBS0. Trizol (Invitrogen) was added 
according to the weight of the tissue as described by the manufacturer. The tissue 
was homogenized using an ultra-turrax mixer followed by centrifugation to remove 
remaining tissue fragments. For RT-PCR, 1 μg of RNA was used.  
Dissected embryo fragments were dissolved in Trizol by shearing through a 19G 
hypodermic needle and processed as described for CFU-F colonies.  
CFU-F RNA processing and preparation of cDNA has been described in Chapter 2. 
Reverse transcription reactions were diluted to 200 μl with de-ionized water, and 2 
μl was amplified in a 25 μl PCR reaction, using the primer pairs listed in Table 1 
with either SuperTaq (SphaeroQ, the Netherlands) or Taq DNA Polymerase 
(Invitrogen). Reaction conditions optimized for each primer pair are available on 
request. PCR reactions were analyzed by agarose gel electrophoresis as described in 
Chapter 2. 
 
 
Histological analysis of reporter gene expression 
E11.5 and E12.5 day embryos were dissected from the uterus, fixed in PBS0 
containing 1% formaldehyde and 0.2% glutaraldehyde for 1 hour at 4°C, and 
washed with PBS0.  
 
Foetuses (E16.5-E18.5) were killed by decapitation; femur and sternum were 
dissected out and most of the overlying muscle was removed prior to fixation for 45 
minutes as described above or for 2 hours on ice. Yolk sac or tail was used for 
genotyping with LacZ primers (see Table 1). 
Adult mice were killed by cervical dislocation according to institutional guidelines, 
and femur and sternum were dissected out and largely freed of overlying muscle. 
These bones were split longitudinally, and fixed for 1 hour. 
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Embryos and bones were stained for ß-galactosidase activity for 18-24 hours using 
standard procedures but using Xgal at 0.4 mg/ml instead of 0.8 mg/ml. For E16.5-
E18.5 foetuses and adult bones, 0.2% Nonidet NP-40 substitute and 0.1% sodium 
deoxycholate were added to washing and staining solutions to improve staining of 
deeper tissues. Tissues were embedded in paraffin and sectioned and stained as 
described before (327). 
Dishes with CFU-F colonies were washed once with PBS0, fixed for 15 minutes at 
room temperature, washed with PBS0, stained as described above, and 
counterstained with Neutral Red. 
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4.1 Summary 
Hox Proteins plays an important role in hematopoiesis, in both the hematopoietic 
stem cells as well as in lineage resticted cel populations. They are important for 
correct proliferation and differentiatio, and overexpression of Hox genes frequently 
lead to leukemias. Despite their importance in hematopoiesis, nothing is  known 
about the regulatory mechanisms that are responsible for driving Hox gene 
expression in the hematopoietic system. We have searched for putative 
hematopoietic enhancer elements for the HOXA cluster using a transgenic approach. 
However, our results suggest that that the enhancer elements are located outside the 
region that was covered in our analysis. We therefore developed a double retrofitting 
strategy to generate large reporter constructs for identification of these putative 
distant regulatory elements. 
 
 
4.2 Introduction 
Throughout our entire life, blood cells of multiple lineages are produced by a small 
population of hematopoietic stem cells (HSC). This process involves the self-
renewal of HSC, proliferative expansion of progenitor cells, and the progressive 
commitment of progenitors to single lineage differentiation (225). 
 
The Hox family of transcription factors plays an important role in hematopoiesis. 
Deregulation of Hox gene expression effects the proliferation and differentiation of 
HSC and committed progenitors, as has been shown by a number of knockout and 
over-expression studies (reviewed in (1,180,316)). Loss-of-function studies of 
Hoxa9, Hoxb4 and Hoxb3 have shown that these genes are involved in the regulation 
of stem cell self-renewal and repopulation after HSC transplantation. Genetic 
interaction among these genes suggests that they act in a similar pathway 
(32,177,194). These findings are also supported by retroviral over expression studies 
of the human HOXB4 and mouse Hoxa9 genes that resulted in marked increase in 
HSC self-renewal and repopulation abilities (279,314,317). Hoxa9-deficient mice on 
the other hand, also exhibit a variety of differentiation defects in the myeloid and 
lymphoid pathways, which suggests that this gene has multiple functions in 
regulation of hematopoiesis (139,178). Other Hox genes also appear to act at 
multiple levels. Overexpression of HOXB6 for example, leads to expansion of HSC 
and myeloid precursors while inhibiting erythropoiesis and lymphopoiesis (85). 
Overexpression of HOX genes also frequently leads to the development of 
leukemias, as was for example shown for HOXA10 (315) and for HOXB6 (85). 
Aberrant activation of HOX genes is a common event in human myeloid leukemia 
and many Hox proteins have shown to contribute to human leukemogenesis 
(10,221,232). Expression of Hox genes in primary leukemic cells shows 
characteristic patterns that are distinct for specific types of leukemia (45). In 
addition, high-level expression of HOXA9 in human acute myeloid leukemia (AML) 
is significantly correlated with resistance to treatment (107). Mixed lineage 
leukemia's (MLL) caused by chromosome rearrangements involving the HOX 
maintenance factor MLL, account for the majority of infant and treatment-related 
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secondary leukemias, and in general carry an extremely poor prognosis (16,73). 
MLL can be distinguished from other leukemias by a distinct gene expression 
profile, which includes differential overexpression of HOX genes. It is assumed that 
this is due to inappropriate activation of HOX gene expression by the MLL fusion 
proteins (12).  
 
The expression of Hox genes in hematopoietic cells has not been investigated 
systemically, but for a reasonable number of these genes expression in different 
hematopoietic lineages in human and mouse has been established. Hox genes were 
first shown to be expressed in several human and murine immortalized 
hematopoietic cell lines (163,286), but later also in several subsets of hematopoietic 
cells from the bone marrow (215,248,278). Expression of Hox genes is markedly 
higher in progenitor populations than in mature blood cells (179,248,278) and the 
expression appears to be mainly restricted to the HOXA and HOXB clusters 
(30,278). Despite the increasing knowledge about the function of Hox genes in 
normal hematopoiesis and leukemia, nothing is known about the regulatory 
sequences that are responsible for driving Hox gene expression in the hematopoietic 
system.  
We started to search for putative hematopoietic enhancer elements for the HOXA 
cluster by testing BAC/PAC constructs covering the complete HOXA cluster and 
flanking sequences at either side in transgenic mice. These transgenes failed to drive 
expression in hematopoietic cells, suggesting that the enhancer elements are located 
outside the region covered by these constructs. We also describe the development 
and implementation of a novel, double retrofitting strategy to generate large reporter 
constructs for identification of such distant regulatory elements. 
 
 
4.3 Materials and Methods 
BAC constructs 
RP1-170O19 and RP11-881P4 have been described in Chapter 3. Five other 
overlapping BAC constructs flanking both sides of the HOXA cluster spanning 
around 1Mb of genomic sequence in total, were obtained from the BACPAC 
Resources Center (Oakland, CA) as agar stabs. A few colonies per clone were 
checked for stability by comparing the restriction digestion pattern obtained with a 
frequently cutting restriction enzyme (data not shown). Most of the clones were 
sequenced with SP6 and T7 primers to map the ends of the insert. The results are 
shown in Table 1 and Figure 2  
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Table 1. Location of the ends of genomic BAC clones 
BAC name NCBI ID T7 end SP6 end 
RP11-881P4 - AC004080 61492   
AC073472 
69097 
RP11-26E06 - AC004080  96123 
AC004009 
27287 
RP11-749D01 - AC004996  99830 
AC007130   
19019 
RP11-422K18 - AC007130 26155 
AC005091 
86712 
RP11-812K17 AC07315 See NCBI accession number 
RP11-232C20 - Not sequenced yet 
RP11-627P22 AC07374 See NCBI accession number 
 
 
Retrofitting vectors 
Both pRetro-Sp/L-ΔI and pRetroES-I are modified version of pRetroES (334).   
The pRetroES vector (334) was modified as follows. First, an oligonucleotide 
containing SalI and I-SceI sites was ligated into the SacI and NotI sites of pRetroES, 
creating pRetroES-I (see also Chapter 3). This vector was used to construct pRetro-
Sp/L. For this, the 1.8Kb XbaI-XbaI fragment containing the GST-loxP-Cre coding 
region was removed from pRetroES-I. The NotI site was replaced by BglII. The 
PGK-neo cassette was removed as an ApaI-HindIII fragment, and replaced by an 
ApaI-SalI-PmeI-NheI-HindIII polylinker. The ampicillin resistance gene was 
removed by digesting with HpaI and SwaI, and replaced by a 2.0 Kb HindIII 
fragment from pNELγI (153) containing the spectinomycin resistance gene. 
Subsequently, a 1370 bp SphI-PshAI fragment containing the lacI gene was excised 
from pET28-b(+) (Novagen), fitted with SacI linkers and ligated into the SacI site of 
the SpR retrofitting vector. A novel self-inactivating 6His-loxP-Cre fusion protein 
expression cassette was created as follows. A 2.0Kb XbaI-HindIII fragment 
containing the GST-loxP-Cre cassette was subcloned from pRetroES into pET28-
b(+) (Novagen) digested with NheI and HindIII. Next, a ~720bp NdeI fragment 
encoding the GST moiety was removed from this construct, fusing the 6His tag from 
the pET vector to the loxP-Cre open reading frame. The XbaI site in the terminator 
region of the Cre cassette was destroyed by filling-in with Klenow fragment. 
Finally, the 6His-loxP-Cre cassette was re-inserted as an XbaI-HindIII fragment into 
the modified vector backbone after partial digestion with HindIII and digestion with 
XbaI. To generate pRetro-Sp/L-ΔI, the I-SceI site was destroyed by digestion and 
T4 DNA polymerase treatment.  
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Hoxa7s-Venus 
The 2.7kb SacI-SacI fragment containing a Hoxa7 enhancer/promoter region 
(161,235,256) was derived from RP21-500A4 (RPCI-21, 29S6/SvEvTac mouse 
library) (230) by restriction digestion, and cloned in the SacI site of the multiple 
cloning site of pVenus-N1 (219,261). 
The Hoxa7s-Venus fragment was isolated from the vector sequence and cloned into 
pRetro-Sp/L-ΔI. A CMV-EGFP reporter was obtained from pEGFP-N1 and cloned 
into pRetro-Sp/L-ΔI. For both reporters the direction of transcription is the opposite 
of that of the Cre gene. 
 
Cell sorting and cDNA preparation 
Mice were killed according to institutional guidelines. The bone marrow from adult 
FVB/N and transgenic mice bearing the RP1-170O19I or RP11-881P4 construct (see 
Chapter 3 for details), was collected from the femur and tibia in phosphate buffered 
saline (PBS0) (Gibco) with 10% fetal bovine serum (FBS) and 2 mM EDTA by 
flushing and scraping. Nuclei were counted on a Beckman Coulter Z1 after cell lysis 
using Zap-oglobin II reagent (Beckman Coulter Inc.). Lysis of red blood cells prior 
to sorting was done as follows. Cells were pelleted at 1000rpm for 5 minutes and 
resuspended in 1 ml of lysis buffer (150 mM NH4Cl, 10 mM NaHCO3, 2 mM 
EDTA). Lysis was allowed to proceed for 3-4 minutes at RT, then 6 ml of medium 
was added and gently mixed. A layer of approx 0.5 ml of FBS was placed at the 
bottom of the tube with a pasteur pipette. The cells were centrifuged for 5 minutes 
without disturbing the layers and the supernatant was removed. Cells were 
resuspended in PBS0 with 1% FBS and 0.1 mM EDTA. Cells were stained with 
directly FITC or PE-labelled antibodies for 30-40 minutes on ice with 1x106 cells 
per 100 μl buffer. Antibodies were obtained from e-bioscience and each batch was 
titrated for optimal concentration before usage.  
Cells were sorted on either an AutoMACS or a FASC-Vantage, both from Becton-
Dickinson. For analysis of gene expression after FACS, a minimum of a 100.000 
cells with a purity of >95% were collected. The cells were pelleted and lysed in 
Trizol (Invitrogen). RNA isolation and reverse transcription were performed as 
described for CFU-F in chapter 2. Depending on the cDNA quality, 1-5 μl of the RT 
reaction (25 μl), was used for PCR, using the Hoxa and HOXA primers described in 
chapters 2 and 3.  
 
Retrofitting 
In vivo retrofitting was performed as described by as described by Wang et al (334). 
Retrofitting BACs in both loxP sites resulted in decreased proliferation of the host 
bacteria, and these constructs tended to lose the pRetro vectors in liquid cultures 
grown to high density. Also, double retrofitting was only successful when pRetro-
Sp/L-ΔI-Hoxa7s-Venus was retrofitted first, followed by pRetroES-I (Figure 3). 
After the second transformation, no colonies could be found the next day, but after 
at least 24 hours, clusters of satellite colonies started to appear. These satellite 
clusters were then streaked onto a fresh plate and if double retrofitting was 
successful, colonies appeared after approximately 16 hours of incubation. The 
colonies were screened by PCR to determine the sites of insertion of the retrofitting 
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constructs, using primers F1 (5’-TCAGCGTGAGACTACGATTC-3’), F2 (5’-
GTTGCTACGCCTGAATAAGTG-3’) and R (5’-TCGACCGGTAATGCAGGCA-
3’) as described by Wang et al, 2001 (334) for pRetroES. These primers also work 
for pRetro-Sp/L-ΔI-Hoxa7s-Venus and pRetro-Sp/L-ΔI-CMV-EGFP. However, to 
obtain a specific product for these vectors, primer R was replaced by EGFP-fw (5'-
TGGATAACCGTATTACCGCCATGC-3'). This was important, as during the 
second retrofitting the vectors can exchange their integration site.  
 
Low DNA yields were obtained from both small and large scale plasmid 
preparations, as the bacteria (DH10B) tended to lose their doubly retrofitted BAC 
construct. For large-scale cultures, one colony was inoculated in 100 ml of LB 
medium containing 25 μg/ml ampicillin and 25 μg/ml spectinomycin. After over-
night incubation at 37oC with shaking, the cultures were centrifuged at 3500 rpm for 
10 minutes. As a large percentage of the bacteria had died, the centrifuged culture 
was cloudy and only a relatively small pellet of cells was recovered. The medium 
was discarded and the pellet resuspended in three litres of fresh culture medium. 
These cultures were incubated at 37oC while shaking for approximately 3-4 hours 
until they had reached a maximum optical density of 0.5 at 595 nm.  
The DNA was isolated using Qiagen columns (1 Q500 column per litre of culture) 
according to the manufacturer’s manual except that no intermediate precipitation 
step before loading the column was performed, and the lysate was directly loaded on 
the column. For elution, the elution buffer was heated to 50oC. A three-litre culture 
typically yielded between 20-50μg of doubly retrofitted BAC DNA. Caesium 
chloride equilibrium density gradient centrifugation preparations were not successful 
with these cultures due to the high protein-to-plasmid DNA ratio. 
 
 
Nucleofection 
K562 cells were cultured in RPMI1640 with GlutaMax, collected by centrifugation, 
and resuspended in Cell line nucleofector solution V (Amaxa) at a density of 107 
cells / ml. 100 µl of this suspension was transfected with 1-3 µg of DNA in an 
Amaxa nucleofector device using program T-16. Cells were examined by 
epifluorescence microscopy 24 hours after transfection. 
 
 
4.4 Results 
Analysis of transgene expression in hematopoietic cells 
Most HOXA transgenes were readily detected in freshly isolated total bone marrow 
of RP-11881P4 and RP1-170O19I transgenic mice (Fig. 1). To establish whether the 
transgenes are expressed in hematopoietic cells, we analysed HOXA gene 
expression in various hematopoietic cell populations purified from transgenic mice 
carrying RP11-881P4 (all three lines) or RP1-170O19I (line 1 and 2; see Chapter 3). 
Hox gene expression was reported to be absent or expressed or at very low levels in 
terminally differentiated blood cells (179,278). We confirmed these results by RT-
PCR on mature cell populations isolated by Magnetic Activated Cell Sorting 
(MACS) with lineage-specific (Lin) antibodies MAC-1 (macrophages), B220 (B 
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cells), TER119 (erythrocytes), GR-1 (granulocytes) and CD3e (T cells). In all of 
these populations, we found expression of the endogenous Hoxa genes to be very 
weak or absent. Only B cells and macrophages showed weak expression of Hoxa7, 
Hoxa9 and Hoxa10, which could not consistently be detected (data not shown). 
Separation of the B cells into a mature fraction (B220+/IgM+) and a Pre-B cell 
fraction (B220+/IgM-) by Fluorescent Activated Cell Sorting (FACS) confirmed that 
more genes could be detected in the more immature population (see Fig. 1. 
However, in the very early Pro-B cells (CD19+/ CD117-) a decreased number of 
expressed genes could be detected. This is probably in part due to the small 
population size that significantly increases the time required for separation, 
increasing cell-death and yielding lower quality cDNA. A very similar set of genes, 
compared to Pre-B cells, was expressed in the common progenitor population 
(CD45+Lin-) (see Fig. 1). In none of these populations did we detect expression of 
the HOXA transgenic constructs. This strongly suggests that the sequences 
responsible for expression in these cell populations are located outside RP11-881P4 
and RP1-170O19. 
 
Long-distance enhancers 
It has been proposed that distant enhancers would control expression of Hox genes 
in tissues that represent evolutionary “novelties”. These are thought to be acquired 
in evolution after cluster duplication, at a position that does not interfere with pre-
existing Hox functions (70,300). Expression of Hox genes in the hematopoietic 
system might also be a function that has been acquired relatively recently in 
evolution. It is known that enhancers can act over very large distances up to almost 1 
Mb (184). Enhancers are often able to control transcription of several genes that are 
unrelated in structure or function, a mechanism that underlies the method of classic 
enhancer trapping experiments (89). This may result in co-activation of unrelated 
genes that are positioned in the proximity of a long-distance enhancer, as for 
example was observed for the Hoxd digit enhancer (300). We looked at expression 
of several genes that are positioned over 2 Mb at both sides of the cluster for their 
expression in hematopoietic cells. If genes at one side of the cluster would 
systematically be expressed in hematopoietic cells in contrast to genes on the other 
side of the cluster, this could potentially indicate the position of a hematopoietic 
enhancer. However, equal numbers of genes at both sides were either reported to be 
expressed in hematopoietic cDNA libraries (NCBI gene reports), or expressed in the 
human leukemia-derived cell lines U937, HL-60 and K562 (data not shown). These 
experiments therefore yielded no clues about the location of a putative enhancer for 
the HOXA cluster.  
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A. 
 
B. 
       Total bone marrow 
HOXA/Hoxa 1 2 3 4 5 6 7 9 10 11 13 
Endogenous + + + + +  + + + + - 
Transgene + + + +  + +  + + - 
 
      B220+/IgM-      B220+/IgM+ 
HOXA/Hoxa 1 2 3 7 9 10  1 2* 3 7 9* 10 
Endogenous + + + + + +  - +/- - - +/- + 
Transgene - - - - - -  - - - - - - 
* Inconsistent between different experiments 
 
      CD19+/CD117-      CD19+/CD117+ 
HOXA/Hoxa   2 3 7 9  2 3 7 9 
Endogenous + + + +  - - + + 
Transgene - - - -  - - - - 
 
     CD45+/lin- 
HOXA/Hoxa 1 2 3 7 9 
Endogenous + + + + + 
Transgene - - - - - 
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Figure 1. Analysis of Hox gene expression in transgenic mouse lines 
(A), analysis of Hox gene expression in the B-cell lineage. FACS plots of the sorted cell 
populations are shown on the left, and RT-PCR data in the right. The experiment shown 
was done with mouse line 881P4-2, and is representative for the other transgenic mouse 
lines. (B), summary of analysis of Hox gene expression in different FACS-sorted 
hematopoietic cell populations from RP11-881P4 and RP1-170O19I transgenic mouse 
lines. The absence or presence of a PCR product is indicated by (-) or (+) respectively. 
The subset of differentially expressed genes shown in this panel were selected for their 
reproducibility of detection in multiple FACS sorting experiments on different transgenic 
lines. 
 
 
Generation of a reporter construct 
We designed reporter constructs to continue a transgene-based approach to identify 
the HOXA hematopoietic enhancer,. Since Hoxa7 was readily detectable in several 
of the more immature cell populations (see Figure 1, we decided to use a Hoxa7 
reporter construct, and to retrofit this onto BAC clones covering a genomic area of 1 
Mb around the HOXA cluster (Figure 2). The 2.7 kb upstream Hoxa7 
promotor/enhancer fragment (Hoxa7s) that we used in this study was reported to be 
capable of driving regionally restricted expression in mouse embryos (161,235,256). 
Fluorescent proteins had also been successfully used to track expression of Hox 
genes during embryogenesis (106,236,303). Hoxa7s was cloned in front of the 
Venus fluorescent protein reporter gene in order to detect the expression in living 
cells. Venus is a modified version of EYFP that exhibits faster folding of the protein 
and yields brighter fluorescence (219).  
 
We transfected pRetro-Sp/L-ΔI-Hoxa7s-Venus (Figure 3b) in an immortalized 
stromal cell line derived from murine bone marrow. This resulted in fluorescent 
cells that were maintained upon G418 selection, confirming functionality of the 
reporter and the antibiotic selection cassette (data not shown). Transgenic lines 
carrying the Hoxa7s-Venus construct were established to test its function in vivo. 
From one of these, we obtained transgenic embryos showing fluorescence in a 
regionally restricted pattern with an anterior limit around somite 15 (results not 
shown), which corresponds to the anterior boundary reported for this construct 
(255). However, expression was mosaic and no longer observed in later generations, 
probably due to position effect variegation at the integration site. 
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Figure 2. Location of genomic clones 
The genomic configuration surrounding the HOXA cluster is shown at the top, and 
genomic inserts of the BAC clones used in this study, and of PAC clone RP1-170O19, are 
schematized below. The T7 and SP6 ends are indicated where known. 
 
 
Retrofitting of BAC clones 
Cloning of Hoxa7s-Venus and CMV-GFP reporters, as well as other inserts into the 
retrofitting vector pRetroES (334) proved problematic as a high frequency of 
rearranged clones was observed. We therefore modified the retrofitting vector in 
several ways to improve its integrity and the stringency of selection. The more 
stringently regulated LacI promoter was used to replace the Tac promoter. Since the 
GST-loxP-Cre fusion protein is incompletely characterized and was shown to have 
decreased specificity with regard to the wild type and variant loxP sites (334), we 
replaced GST with a small Histidine tag. The ampicillin resistance was replaced by 
spectinomycin, to provide more stringent selection. The mammalian neomycin 
resistance cassette was removed and replaced with a multiple cloning site, to 
facilitate cloning of reporter cassettes.  
The modified vector, pRetro-Sp/L, exhibited greatly improved stability and was 
successfully used to clone and retrofit Hoxa7s-Venus and CMV-EGFP expression 
cassettes. However, this construct still showed a lack of specificity for the LoxP 
sites. The vector still integrated in both the loxP and lox511 sites with about equal 
frequencies (data not shown), similar to what was observed for the original 
pRetroES (334).  
 
 
Testing BAC constructs in vitro 
In keeping with the deregulation of HOX gene expression in the context of 
leukemias, several established hematopoietic cell lines derived from leukemia 
patients express HOX genes (163,286).  It is unknown whether HOX gene 
expression in these cell lines is driven by the continued activity of hematopoietic 
enhancers, or whether it is due to other mechanisms, e.g., maintained by the 
polycomb/trithorax-group proteins after being initiated by activity of the enhancers 
at an earlier stage. If all factors required for enhancer activity are still present in 
these cells, they might allow rapid screening of reporter constructs. Knowing that 
RP11-881P4 is unable to express HOXA genes in hematopoietic cells, this construct 
can be used as a negative control in testing such cell lines. 
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Figure 3. Retrofitting vectors  
(A), scematic drawing of pRetroES-I (334). (B), scematic drawing of pRetro-SP/L-ΔI-
Hoxa7s-Venus-. (C), scematic drawing of the retrofitting procedure. BACs with different 
genomic inserts in vector backbone pBACe3.6 are retrofitted with a retrofitting vector in 
both LoxP sites present on this vector. Shown is the integration of pRetroES-I in LoxP and 
pRetro-SP/L-ΔI-Hoxa7s-Venus in Lox511. All Retrofitting vectors can be integrated in 
either LoxP site indicated by the black arrow. SPEC, Spectinomycin resistence; Neo, 
Neomycin resistance; AMP, Ampicillin resistance. 
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Figure 4  
Transfection of retrofitted BAC and PAC constructs. 
K562 cells were untransfected (A, B), or transfected 
with  pCMV-EGFP (C, D), PAC RP1-170O19 retrofitted 
with pRetro-Sp/L-CMV-EGFP (E, F), or BAC RP11-881P4 
retrofitted with pRetro-Sp/L-CMV-EGFP (G, H). A, C, E 
and G, phase contrast plus fluorescence image. B, D, 
F and H, fluorescence image. 
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To enable screening of the BACs in vitro by transfection into hematopoietic cell-
lines, the loxP and lox511 sites on either side of the genomic insert were retrofitted 
with both pRetro-Sp/L-ΔI-Hoxa7s-Venus and pRetroES-I, in which the first 
construct provides the reporter gene and the second construct a neomycin selection 
cassette and a unique I-SceI site for linearization. We selected clones that contained 
the reporter gene near the end of the insert that faces the HOXA cluster in the normal 
genomic configuration, to avoid possible complications due to presence of insulator 
sequences in the insert, or to the presence of vector sequences between the insert and 
the reporter construct. If possible, we also maintained the same orientation of the 
genomic insert relative to the direction of transcription of Hoxa7. Using this 
approach, we retrofitted a set of six overlapping BAC clones covering the regions 
between the HOXA cluster and its neighbouring genes, SCAP2 and HIBADH (see 
Fig. 1 and Table 2).  To establish proof of principle, we introduced BAC RP11-
881P4 and PAC RP1-170O19, each retrofitted with an EGFP reporter driven by the 
strong CMV promoter, into the K562 erythroleukemia cell line using nucleofection. 
Compared to a small construct carrying the same reporter, which was very 
efficiently transfected (Fig. 4C, D; compare to 4A, B), the BAC and PAC constructs 
yielded considerably fewer cells expressing detectable levels of fluorescent protein, 
although some cells were fairly bright (Fig. 4E-H). This difference probably reflects 
at least in part the fact that the concentration of DNA molecules in the BAC/PAC 
transfections is at least an order of magnitude lower than for pCMV-EGFP. 
 
Table 2. Overview of retrofitted BAC clones 
clone Lox site pRetro inserted 
RP1-170O19 LoxP pRetro-Sp/L-ΔI-CMV-EGFP 
LoxP pRetro-Sp/L-ΔI-CMV-EGFP 
RP11-881P4 
Lox511 pRetroES-I 
LoxP pRetroES-I 
RP11-26E06 
Lox511 pRetro-Sp/L-ΔI-Hoxa7s-Venus 
LoxP pRetroES-I 
RP11-749D01 
Lox511 pRetro-Sp/L-ΔI-Hoxa7s-Venus 
LoxP pRetroES-I 
RP11-422K18 
Lox511 pRetro-Sp/L-ΔI-Hoxa7s-Venus 
LoxP pRetro-Sp/L-ΔI-Hoxa7s-Venus 
RP11-812K17 
Lox511 pRetroES-I 
LoxP Not determined yet 
RP11-232C20 
Lox511 Not determined yet 
LoxP pRetro-Sp/L-ΔI-Hoxa7s-Venus * 
RP11-627P22 
Lox511 pRetroES-I 
* BAC insert is in opposite orientation relative to the direction of Hoxa7 transcription 
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4.5 Discussion 
We have investigated expression of Hox genes in hematopoietic cells of different 
lineages using cell sorting and RT-PCR analysis, and found that overall, the 
progenitor cell populations express more Hox genes at detectable levels than 
terminally differentiated cells of various lineages. This finding is consistent with 
previous data obtained from mouse and human bone marrow (248,278). 
Expression of several Hoxa genes could be reproducibly detected, although fairly 
large numbers of cells were required for detection. We recently investigated mice 
carrying a green fluorescent protein reporter inserted into Hoxa2, which is readily 
detectable in embryos (236). Hoxa2 is one of the more robustly expressed genes in 
the cell populations we analyzed, but the fluorescence could not be detected by 
FACS analysis in hematopoietic cells from the bone marrow (data not shown). We 
assume this reflects the low expression levels of Hox genes in hematopoietic cells.  
 
Using human- and mouse-specific primers for the more robustly expressed genes, 
we then analyzed several transgenic mouse lines carrying large transgenes covering 
the human HOXA cluster. None of these were expressed in purified hematopoietic 
cell fractions, strongly suggesting that enhancers for the hematopoietic system are 
located outside these constructs. It is possible that our failure to detect transgene 
expression is due to impaired functioning of the putative human enhancer in the 
context of murine cells. However, given the high degree of similarity between 
mouse and human, this seems highly unlikely. Some indirect support for this notion 
is provided by enhancers from avian and teleost Hox clusters which are functional in 
murine embryos e.g. (7,199), and the hematopoietic stem cell enhancer for the 
murine SCL/TAL-1 gene is also active in Xenopus (109).  
 
We have developed a strategy for identifying distant enhancers using conventional 
transgenic analysis in vivo and in vitro, which can be easily adapted to other genes. 
The collection of BAC constructs described here covers the most likely region in 
which these enhancers may be located, and can now be tested. However, as our data 
suggest that expression of Hox genes in hematopoietic cells is below the detection 
limit of fluorescent proteins, it may be necessary to replace Venus with a more 
sensitive, enzymatic reporter such as lacZ.  
 
It has been shown that regulatory DNA elements communicate with distant target 
genes through direct physical interactions. Several methods have recently been 
developed that allow identification of these physical interactions between distant 
DNA sequences, and are therefore applicable to identification of distant enhancers 
(reviewed in (295,302)). One of these methods is the Chromosome conformation 
Capture (3C) technology (68) with is based on the quantitation of cross-linking 
frequencies between two DNA fragments as a measure of their frequency of 
interaction in the nuclear space. This technique has succesfully been applied to 
analyse the conformation of a 200 kb region spanning the mouse β-globin gene 
cluster in its active and inactive transcriptional state  (319). However, for this 
technique a prediction about the possible inaracting sequences is required. In our 
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case not only the location of the enhancer is unknown, also the responsive sequences 
around the genes has not been determined. Another issue in using this technique 
might be the large number of cells that is required for the analysis, which could be a 
disadvantage when working with progenitor cells. Using an established 
hematopoietic cell line instead might circumvent this problem. 
 
Advanced technology that allows the identification of physically interacting loci 
without a-priori knowledge about the genomic organisation, based on the 3C method 
has also been developed. One of these methods is the open-ended Chromatin 
Conformation Capture approach that was used to study the chromosome dynamics 
of the Hoxb1 gene during the induction of its expression in the context of retinoic 
acid-induced differentiation of mouse embryonic stem (ES) (339). In the standard 
3C procedure the abundance of specic ligation products is determined by 
quantitative PCR. In the open ended 3C the technique is expanded by replacing the 
directed quantitative PCR with an inverse-PCR. These inverse-PCR products can 
then be cloned and sequenced allowing the identification of unknown sequences 
legated to the locus of interest. This method has, however, not shown to reveal 
functional interactions between genes and regulatory elements. This is most likely 
due to the apparent high accessibility of this locus, resulting in a very large number 
of potential interacting sequences over several hundreds of kilo bases.  
Another technique based on the 3C method is the 4C technology, which yields a 
genome-wide overview of both in cis and in trans interactions of a sequence of 
interest (294). Like 3C, 4C technology depends on the selective ligation of cross-
linked DNA fragments to a choosen target site. Then, all the crosslinked DNA 
fragments are amplified via inverse PCR. Tailored microarrays are used to 
simultaneously analyze the captured fragments. In its present implementation, it is 
applicable only to very long-distance interactions, as interactions in a region of 
several megabases surrounding the gene of interest are completely saturated (294). 
However, it seems possible that it could be adapted through dilution of the imput 
material to identify elements at intermediate distances, where we suspect the 
hematopoietic enhancers are located. Further investigation is needed to test the 
applicability for the Hox locus. 
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5.1 Introduction 
During development, pluripotent embryonic stem cells are responsible for the 
formation of tissues and organs from all three germ layers. In post-natal life these 
tissues and organs are subject to cell turnover and injury. To be able to substitute for 
a loss of cells, adult tissues contain of tissue-specific stem or progenitor cells. The 
presence of these tissue-specific stem cells, has been shown for a large number of 
organs and include neuronal stem cells in brain (147), oval stem cells in liver (86), 
cardiac stem cells in heart (23,176), different types of epithelial stem cell in the skin 
(35), and of course the very well studied hematopoietic stem cells (HSC) in the bone 
marrow (223). Many studies have also been dedicated to mesenchymal stem cells 
(MSC) (241). Less then fifty years ago, MSC were initially discovered as osteogenic 
progenitor cells able to form a stroma that can support hematopoiesis (91,94). These 
cells were soon attributed with increasingly more functions and characteristics.  
 
 
5.2 MSC: stem cells or progenitors 
Stem cells are defined as cells that are clonogenic, self-renewing, and have a 
multipotent differentiation potential. One of the caveats in MSC biology is that 
basically every multipotent (progenitor) cell that is capable of forming CFU-F 
colonies and able to differentiate towards some mesenchymal cell types is defined as 
an MSC in the literature. Also, self-renewal of MSC has not been very well defined 
as in vivo demonstration of repopulation and self-renewal, analogous to the assays 
that exist for HSC has proven to be very challenging for MSC (133). Culture-
expanded human MSC usually stop proliferating before 40 population doublings, at 
which time the cells become bigger and more flattened. A lot of variation has been 
shown between different culture conditions and the age of the donors (reviewed in 
(271)). In addition, MSC do not represent a homogeneous population of stem cells, 
as it is well established that MSC derived from different locations have distinct 
molecular en phenotypic characteristics (127,241,242,330). Besides the 
heterogeneity between MSC from different origins and preparations, the cultures are 
usually also composed of a mixed heterogeneous cell population. Finally, there is no 
standardized method for isolating and culturing MSC. All these variables make it 
difficult to define the exact properties of MSC and to compare the outcome of 
different studies. To address this issue, some criteria to define human MSC have 
been proposed (74), but these criteria are still too general and will most likely be 
applicable to most of the published studies. 
  
In addition to MSC, several tissues were also shown to contain the totipotent Mouse 
Adult Progenitor Cells (MAPC). MAPC are like MSC purified through plastic 
adherence and are likely to be co-purified in the initial MSC cultures, but afterwards 
require specific culture conditions for their enrichment (144,145). Also, a population 
of multipotent mesodermal cells has been isolated from the bone marrow based on 
their SSEA-1+ expression. These cells can either be directly isolated by FACS from 
the bone marrow or derived via CFU-F assays. They were able to contribute to most 
mesodermal lineages in vivo, including hematopoietic cells (8). The hierarchical 
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relationship between MAPC, MSC, mesodermal progenotor cells, and all other 
poorly defined tissue specific stem cells is unfortunately still not clear. Especially, in 
the present era of stem cell biology and cellular therapeutics it is extremely 
important to revisit the definitions and relationships of all different stem cells that 
have been described in literature. Also more precise molecular and cellular markers 
to define subsets of MSC and standardization of protocols for expansion of MSC are 
needed. This will hopefully allow researchers to establish a clear hierarchical 
description of the wide range of stem cells. 
 
 
5.3 Trans-differentiation of MSC: fact or artefact? 
A controversial issue around MSC is the matter of stem cell plasticity or trans-
differentiation. This is a mechanism by which committed cells from one tissue 
change their fate and give rise to cells of a different type. The idea of stem cell 
plasticity has fascinated researchers for a long time but gained most of its popularity 
about a decade ago when it was shown that for example HSC could be transformed 
into neurons and skeletal muscle, and that the reverse was also possible 
(31,36,58,82,142,143,207). MSC were reported to differentiate into a variety of 
tissues from all germ layers (9,125,128) including cardiomyocytes (154), astrocytes 
(164), lung epithelium (228), endothelial cells (56) and liver cells (277). 
However, it soon became apparent that some of the results could not be reproduced 
in other laboratories (43,155) or were shown to be caused by artefacts (141). A 
detailed piece of work that speaks against any form of the plasticity of HSC was 
done by the Weissman lab that performed single cell transplantation studies with 
HSC, which they tracked by a fluorescent marker in a large set of tissues. No 
evidence was found that these labelled hematopietic cells contributed to “foreign” 
tissues (329). Several trans-differentiation studies could later be explained by cell 
fusion (6,187,313,336,345) and it has now been shown that under some stress 
conditions cells of different lineages can fuse with each other leading to the  
hypothesys that this constitutes a quick emergency repair mechanism (37). Another 
explanation for apparent plasticity is that researchers may have used mixed cell 
isolates that contained undefined or undetectable stem cells of a different lineage 
that were responsible for the observed ‘plasticity’ (167). Recently it was reported 
that MSC could be found in virtually every tissue of the body (65). For other tissue-
specific stem cells, such an analysis of anatomical distribution has not been done, 
but there is increasing evidence that stem cells are more widely distributed than thus 
far presumed (169,205,220). Because MSC in vivo are poorly characterised and 
usually isolated and analysed as a heterogeneous mixture of cells, this makes the 
transdifferentiation experiments prone to ‘contamination’ with other unexpected 
tissue stem cells (169).   
Despite the criticisms, MSC have been used in animal experiments and clinical trials 
to treat a broad range of diseases affecting different tissues. In several of these 
studies, therapeutic transplantations with MSC were shown to be efficacious, which 
is remarkable, given several reports of infrequent engraftment and poor trans-
differentiation efficiency. It was therefore suggested that these results were not due 
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to MSC plasticity but were rather induced by another characteristic of MSC, namely 
their ability to form a supportive stroma (reviewed in (242)). This was also one of 
the first properties attributed to these cells (94). It has now been suggested that MSC 
are not only capable to serve in hematopoietic niches, but also contribute to the 
repair and homeostasis of a wide range of injured tissues (242). The mechanisms 
that have been proposed by which MSC fulfil this task include the secretion of 
soluble factors that block apoptosis and inflammation, stimulation of proliferation 
from the injured host tissue and by stimulating angiogenesis 
(118,119,135,137,218,227,310,318,322,341,352). 
Some of these properties (118,119,227,322,341) align well with the previously 
observed immunosuppressive properties in therapeutic bone marrow transplantation 
(17,351). A function of MSC in general tissue homeostasis also correlates very well 
with their widespread distribution throughout the adult body. A role in angiogenesis 
is strongly supported by observations, which showed that MSC may reside in the 
blood vessel walls as multipotent pericytes. This hypothesis was already postulated 
in 1988 by Owen and Friedenstein (231) and there is increasing evidence that 
supports this hypothesis (reviewed in (64,149,288)). In Chapter 3 we showed the 
presence of β-galactosidase expression in some blood vessels within the sternum and 
femur bone marrow cavities from a Hoxb8-LacZ transgenic mouse line, in which 
Hoxb8 is driven by a region-specific enhancer element. Isolation of these β-
galactosidase expressing cells from the vasculature and comparison of their Hox 
code to the CFU-F colonies that we routinely obtain from these locations might 
reveal whether these cells are related to each other.  
 
 
5.4 Embryonic origin of MSC 
The complete lack of knowledge about the foetal origin of MCS is also in part 
responsible for its poor definition. Like in the adult, MSC can also be found in a 
variety of foetal tissues, but thus far it is unclear how these are related. It is for 
example not known whether MSC are derived from a common precursor, or whether 
they arise independently in different tissues with distinct characteristics. The 
question what the relationship is between MSC from different tissues could be 
addressed by clonal analysis or fate mapping (reviewed in (57,151,238)). Several 
different forms of fate mapping have been reviewed by Clarke and Tickle (57). 
Besides the invasive physical fate mapping experiments that involve the 
transplantation or direct labelling of a group of cells during development, genetic 
fate mapping has been developed. Genetic fate mapping, based on the expression of 
a marker gene under control of a tissue specific promoter, allows non-invasive cell 
labelling which makes it applicable to mouse studies. However, care should be taken 
to characterise the promoter activity in detail as this may otherwise result in 
unexpected cell labelling in different tissues. For fate mapping of MSC, a promoter 
with activity in the mesodermal lineage may be analysed to confirm the proposed 
mesodermal origin. Because of the wide-spread activity of most lineage committed 
genes during development, this could be combined with an inducible reporter 
activation that allows inductions over a short time-frame. To be able to correctly 
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interpret the results, the heterogeneous nature of the MSC culture must first be 
characterised in detail. In addition extensive analysis of background expression 
versus effective activation should be determined. In Chapter 2 of this thesis some 
classical fate mapping experiments have been discussed that showed that the bone 
marrow stroma is derived from the limb primordia (150,181). However this is in 
contradiction with the Hox codes that we observed in MSC we isolated from derived 
from individual vertebrae. These patterns did not correspond to the embryonic 
prevertebral Hox codes and were suggestive of an origin different from the vertebral 
primordia. Our studies described in Chapter 3 also suggest that there in no linear 
relationship between the sternum or femur primordia, and the MSC isolated from 
these locations from the adult mouse. Absence or presence of a β-galactosidase 
staining in fetal tissues could not be correlated with LacZ expression or β-
galactosidase staining in the adult MSC. Genetic clonal analysis of MSC could be a 
powerful tool that might contribute to a better understanding of the diversity, 
distribution and potential of MSC. Especially knowledge of the origin and 
distribution of MSC could also lead to a better understanding of how and when 
cultered MSCaquire their topographic Hox codes.  
 
 
5.5 Regulation of Hox genes in MSC 
Hox genes are well known for their role in tissue specification and in cell identity 
during embryonic development. These genes may also play a role in the 
establishment of tissue specific variation of MSC characteristics. In Chapter 2 it was 
described that cultured MSC display Hox genes expression patterns that correlate 
with their anatomical origin rather than tissue type. It is unclear when the cells 
obtain this pattern, and how this pattern is maintained during culture. To fully 
understand the establishment of these patterns it is important to understand where 
MSC first appear in the body during development and how this correlates with the 
embryonic Hox code. Related questions to this topic are: (i) Is ectopic expression of 
Hox genes in adult MSC sufficient to reprogram positional identity. (ii) Is the MSC 
gene expression program instructed by the surrounding tissue? The above-
mentioned clonal analysis may provide an answer to the question whether the MSC 
Hox codes are induced by cues from the surrounding tissue or are completely cell-
autonomous. These issues however could perhaps more efficiently examined in 
transplantation studies and forced in vivo overexpression of Hox genes in MSC.  
In addition, it is also interesting to identify the regulatory elements that are 
responsible for the establishment of the expression of Hox genes in MSC. In Chapter 
3 it was described that large constructs that span most of the HOXA cluster produced 
a topographic expression pattern that largely resembled the endogenous Hoxa 
expression in MSC. Furthermore, we show for at least the Hoxb8 gene that 
transcription is activated through elements that are located in the proximity of the 
gene. It is unclear whether these elements are the same elements that are responsible 
for mesodermal expression in the developing embryo or that they are specialized 
sequences that are partially overlapping the foetal elements. Surprisingly, using 
these small transgenic constructs a loss of tissue-specific expression was observed, 
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causing ‘ectopic’ expression in MSC from other tissues where this gene normally is 
silent. This suggests that these constructs contain elements that induce gene 
activation, but lack those which regulate appropriate suppression.  
 
One of the mechanisms that could play a role in tissue specific gene suppression and 
therefore contribute to the establishment of the MSC Hox code are micro-RNAs 
(miRNAs). miRNAs are short nucleic acid molecules with an average length of 22 
nucleotides. They exert their effect by binding directly to target messenger RNAs 
and inhibiting mRNA stability and translation. Each miRNA can bind to multiple 
targets and many miRNAs can bind to the same target mRNA, allowing for a 
complex pattern of regulation of gene expression. At several positions in the Hox 
clusters, conserved miRNA expression sites can be found. The produced miRNAs 
have recognition sites in the 3’-UTRs of several Hox transcripts.  
Some studies indicated that miRNAs help to define the regions where Hox genes are 
expressed, thereby contributing to their spatial and temporal specificity of 
expression during development (198,237,344). Some recent studies showed that 
miRNAs are able to mediate regulation of proliferation as well as differentiation in 
several different stem cells (51,124,311). In addition, several miRNAs have been 
shown to correlate with osteogenic and adipogenic MSC differentiation although for 
only a few of these a function has been demonstrated (83,174). To date there is no 
evidence in literature for miRNA involvement in the establishment of the MSC Hox 
code and future studies are required to explore this possibility. However, analysis of 
a Hoxb8-LacZ knock-in mouse (323), in which the 3’ UTR is replaced by a SV40 
PolyA suggests that the 3’ miRNA recognition site in the Hoxb8 transcript is not 
involved in tissue-specific regulation of this gene (Chapter 3). It wil be interesting to 
extend this analysis to other Hox genes that are known to contain a miRNA 
recognition site in their 3’UTR as this could be a one of the mechanisms that 
contribute to establishment the topographic specific pattern.  
 
Other key candidates for the establishment of tissue identity are the PcG and TrxG 
proteins. These proteins play an important role in the maintenance of Hox patterns 
by mediating mitotic inheritance of lineage-specific gene expression programs 
(265). Mice lacking one or more of these proteins usually display a mildly disturbed 
colinear Hox pattern in embryos together with the subsequent homeotic 
transformations.  
A mechanism by which PcG/Trx-G proteins may influence the establishment of a 
Hox pattern can be deduced from the transcriptional repression of Hox genes in 
pluripotent stem cells like embryonic stem cells (ES cells). Although Hox genes are 
normally not expressed in ES cells, all factors required for expression, including 
RNA polymerase II are already present on the promotors while being epigenetically 
suppressed by other factors. A chromosomal region that contains both repressive and 
active histone modifications is called a bivalent chromatin domain (25). This is 
characterized by the presence of both Histone H3 lysine 4 (K4) and lysine 27 (K27) 
methylation within the same genomic region. K4 methylation positively regulates 
transcription by recruiting nucleosome remodeling enzymes and histone acetylases, 
while K27 methylation negatively regulates transcription by promoting a compact 
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chromatin structure (87,252,265,276,296,340). These histone H3 K4 and K27 
methylation marks are catalyzed by trithorax and Polycomb group complexes, 
respectively. The K4 methylated regions of the silent Hox loci are cell type-specific 
and can be up to 60 kb in length, spanning multiple Hox genes (25,117). It is 
hypothesized that the precise locations of the epigenetic modifications of the 
histones are involved in controlling the colinear expression of genes from the cluster 
upon differentiation (13,25).  It is unknown whether similar bivalent structures are 
present in adult stem cells like MSC as well or that these cells only display a 
stabilized epigenetic configuration inherited from for example its fetal precursor. 
However, the fact that the tissue specific Hox codes in MSC are maintained during 
culture and are insensitive to exposure to heterologous tissue or differentiation 
agents (Chapter 2), suggests that the epigenetic patterns in MSC are stably 
maintained via permanent histone marks. Interestingly, this obeservations also 
strongly suggest that the MSC that we obatain upon culture are a commited 
progenitor population rather than a true stem cell source. 
 
 
5.6 Reporter gene expression in MSC 
During our research we have used a mouse strain carrying a fluorescent reporter 
gene under control of the Hoxa2 promoter. Although most of the CFU-F colonies 
expressed Hoxa2 at the transcriptional level, we were unable to detect the 
fluorescence by microscopy and FACS analysis in MSC from bone marrow. Also, 
hematopoietic cells from these animals in bone marrow and fetal liver did not show 
a fluorescent signal that could be detected by FACS analysis.  
Hoxb8 constructs fused to a Lac reporter did in most cases also not result in any 
detectable signal in adult MSC. It is not yet clear whether the absence of detectable 
GFP or β-galactosidase expression is caused by an absence of the protein, 
expression levels too low for visualization, or specific down regulation of 
translation. Analysis of MSC cultured from C57BL/6-Tg(ACTB-EGFP)1Osb/J mice 
(224) that express EGFP under control of the chicken beta-actin promoter and 
cytomegalovirus enhancer, revealed that EGFP could only be detected in a small 
fraction of the MSC cultures (unpublished observation). Similar to our observations, 
it was recently reported that rat bone marrow derived MSC greatly repress 
expression of lentivirus transduced EGFP expression. EGFP in cultured rat MCS 
was detected in less than fifty percent of the culture. EGFP antibody staining 
showed that the cultures also contained cells that expressed EGFP at very low levels, 
undetectable by fluorescence microscopy and FACS analysis. The authors showed 
that this silencing of the GFP gene was caused by DNA methylation. In agreement 
with these results they observed that incubation of MSC with the DNA 
demethylation reagent 5-azacytidine increased the number of cells with detectable 
GFP (122). 
The Escherichia coli lacZ gene, which encodes the beta-D-galactosidase enzyme, is 
one of the most widely used reporter genes in transgenic studies. Many spatial and 
temporal expression patterns of genes and their developmental profiles have been 
identified using lacZ reporter constructs. In postnatal studies on the other hand, 
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LacZ transgenes often function poorly and display variegated expression (62). It has 
been suggested that the GC content in the DNA that is significantly higher than 
encountered in most mammalian genes contributes to methylation mediated 
silencing. However, so far no clear evidence has been provided for this (reviewed in 
(213)). Analysis of our transgenic reporter construct expression should be further 
analysed using antibody labelling to potentially relate the lack of visibility to the 
expression level. Also other Hox genes fused to a reporter gene could be analyzed to 
investigate whether the same detection problems are encountered.  
 
 
5.7 Function of Hox genes in MSC 
After having established that cultured MSC express region specific Hox codes, we 
wondered about the function of Hox gene expression in MSC. As it is unknown 
whether the transcriptional Hox code is translated into functional proteins candidate 
Hox genes for functional analysis in MSC should first be analyzed for their 
expression of translated Hox proteins in MSC cultures. Multiple alternative, 
polycistronic and non-coding transcripts in the Hox clusters have been described 
(26,197,284), which are thought to contribute to the maintenance of an active 
chromatin conformation. The possibility exists that only some of the transcribed 
genes that we detect are actually translated into a functional Hox protein while the 
remaining neighbouring genes only become expressed due to an open chromatin 
state, but are repressed in their translation. 
 
In other stem cell systems it is has been observed that Hox proteins serve a role in 
processes like proliferation and differentiation. Hoxb1 for instance is able to mediate 
the maintenance and expansion of posterior neural progenitor cells. Forced 
expression caused progenitor amplification and reduced the number of terminally 
differentiated cells (110). A similar phenomenon has been observed for HOXB4 and 
Hoxa9: upon over expression this gene is able to mediate hematopoietic stem cell 
expansion in vitro (279,314,317). Also, for several other Hox proteins a role in 
hematopoietic proliferation and differentiation has been described (1,193,316) as 
also discussed in Chaper 4. Based on the knowledge from these and other 
stem/progenitor cell populations it is conceivable that Hox genes are involved in 
similar processes in MSC. In fact, preliminary studies on tamoxifen inducible Hoxa 
cluster knockout mice , suggested a slight proliferative defect upon Hoxa cluster 
reduction (data not shown). These experiments have to be repeated to confirm this 
result. Hypotheses about a function of Hox proteins in differentiation are based on 
observations of tissue specific expression patterns in osteogenic, chondrogenic and 
adipocytic cell types. Expression of several Hox genes has been reported in the pre-
adipocytic cell line 3T3-L1 and transcriptional differences were detected during 
differentiation. The authors also detected expression of Hox genes in murine 
retroperitoneal fat deposits (60). In agreement with this observation, most of the 
HOX genes were shown to be active in human adipose tissue in which they display 
varying expression patterns in different fat deposits. However, it is unclear whether 
these regional differences are topographically related or actually contribute to 
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variation in adipogenic capacities (39,328). Gersch and coworkers studied Hox 
protein expression in adult bone fracture repair, and noticed that Hoxa2 and Hoxd9 
protein levels become upregulated in both chondrogenesis and osteogenesis during 
repair (104). Others have observed that during the osteoblast differentiation process 
of pre-myeloblastic cells HOXA10 is transiently expressed (20). And indeed, direct 
interaction of Hoxa10 with regulatory elements of osteogenesis-specific genes has 
been demonstrated using chromatin immunoprecipitation (123). 
In chondrogenesis, a model was proposed for the function of Hoxc8 and Hoxd4 in 
chondrocyte differentiation (347). However, the effects seem to be related to 
embryonic functioning and could not be confirmed in an in vitro culture system of 
postnatal derived chondrocytes (59). This type of experiments underscores the fact 
that although it is clearly demonstrated that Hox genes play an important role in 
proper skeletal development and growth during embryogenesis, the function of Hox 
proteins in adult mesenchymal tissues cannot be derived from a straightforward 
correlation. 
 
One of the characteristics of MSC is the ability to form a stroma or 
microenvironment that is able to support HSC (48,307) and potentially also other 
tissue specific progenitors (242). Thus far, Hox genes have not been implicated to 
function in the formation of a stem cell supportive stroma. Also, no evidence is 
available that shows the interaction of Hox proteins with the receptors and secreted 
cytokine signals known to be responsible for the maintenance of the hematopoietic 
stem cell niche. In addition, comparative gene expression analysis between 
supportive and non-supportive stromal cell lines derived from the mouse fetal liver 
did not reveal a specific regulatory change of Hox transcripts that could indicate a 
functional role (supplementary data (120)). However, it is conceivable that the 
topographic Hox gene expression contributes to site-specific identity of MSC and 
serves as a blueprint of positional information for mesenchymal tissues during 
homeostasis and repair. This is supported by our observation that the Hox codes are 
intrinsic to the topographic origin of the MSC (Chapter 2). At this moment the 
question whether Hox genes are involved in regulating tissue homeostasis, repair 
and cellular identity in the adult, remains unanswered.   
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Summary 
The adult mammalian body is home to several types of stem cells that are 
responsible for the maintanance of specific tissues or organs. In this thesis I describe 
one of these tissue stem cells; the Mesenchymal stem cells (MSC). MSC can be 
found in many locations throughout the body and are able to form different types of 
mesenchymal cell lineages as for example osteoblasts (bone), chondrocytes 
(cartilage), and adipocytes (fat). MSC can be isolated from these different locations 
and cultured in vitro. When placed into a tissue culture dish, MSC form clonogenic 
plastic adherent colonies in which the cell morphology resembles this of fibroblasts, 
hence the name colony forming unit-fibroblast (CFU-F). MSC isolated from 
different tissues show tissue specific differences reflected in for example their 
propensity for differentiating towards specific lineages.  
 
In Chapter 2, we propose that Hox genes may be involved in determining tissue-
specific properties of MSC. This was suggested as Hox genes are known to play an 
important role in regional specification and organ development in the embryo. We 
investigated the Hox gene expression profiles of CFU-F colonies derived from 
various locations in the body. This revealed that MSC have characteristic Hox 
expression signatures that are specific for their anatomical origin. The topographic 
specificity of these Hox expression patterns is maintained during differentiation, 
suggesting that they are an intrinsic property of MSC.  
 
In Chapter 3, we examined how these topographic expression patterns are 
established at the molecular level, and how they relate to the origin of MSC in the 
embryo. We show that at the regulatory sequences responsible for driving Hox gene 
expression in CFU-F are within the confines of the Hox clusters. We also show that 
known embryonic region-specific enhancers can drive expression in CFU-F, but 
without any topographic specificity. We hypothesize that MSC in bone marrow do 
not originate locally from the same embryonic precursors as the bone they are found 
in, but colonize these from a distinct source. 
 
In Chapter 4 we touch upon a different cell type in which Hox proteins are well 
known to play a role in proliferation and differentiation; the hemotopoietic cells, or 
blood cells. Despite a broad knowledge about the function of Hox genes in normal 
hematopoiesis and leukemia, nothing is known about the regulatory sequences that 
are responsible for driving Hox gene expression in the hematopoietic system. We 
started to search for hematopoietic enhancer elements in the HOXA cluster and its 
direct surroundings. The analysis suggested that the enhancer elements are located 
outside our analyzed region. We also describe the development and implementation 
of a strategy to generate large reporter constructs for identification of the putative 
distant enhancer. 
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Samenvatting 
In het lichaam van een volwassen dier bevinden zich verschillende typen stamcellen 
die verantwoordelijk zijn voor het onderhoud van specifieke weefsels of organen. In 
dit proefschrift beschrijf ik een van deze stamcellen; de mesenchymale stam cel 
(MSC). MSC bevinden zich op veel verschillende plaatsen in het lichaam en zijn in 
staat om verschillende weefsels te vormen, waaronder osteoblasten (bot), 
chondrocyten (kraakbeen) en adipocyten (vet). MSC kunnen uit het lichaam 
geisoleerd worden en gekweekt. De cellen vormen klonogene kolonies op de bodem 
van kweekschaaltjes. De cellen in zo'n kolonie lijken sprekend op een celtype met de 
naam fibroblast en daarom worden deze kolonies dan ook colony forming unit-
fibroblast (CFU-F) genoemd. MSC die uit verschillende weefsels zijn geisoleerd 
hebben kenmerken die specifiek zijn voor de plaats in het lichaam waar ze vandaan 
kwamen. Deze eigenschappen uiten zich vaak in hun mogelijkheden tot het 
differentieren naar de verschillende mesenchymale weefsel types.  
 
In Hoofdstuk 2 stellen we voor dat Hox eiwitten een rol kunnen spelen in het 
bepalen van de weefselspecifieke eigenschappen van MSC. Dit vermoeden was 
ontstaan omdat Hox eiwitten een belangrijke rol spelen in de regio specificatie en 
orgaan ontwikkeling in het embryo. We hebben het expressiepatroon van Hox genen 
in CFU-F kolonies uit verschillende plaatsen uit het lichaam bepaald, en hieruit 
bleek dat MSC karakteristieke expressie patronen hebben die specifiek zijn voor hun 
oorspronkelijke locatie in het lichaam.  
 
In Hoofdstuk 3 onderzoeken wij hoe de locatie specifieke expressie patronen tot 
stand komen op moleculair niveau en of de patronen mogenlijk verwant zijn aan de 
plaats van oorsprong van MSC in het embryo. We laten zien dat de regulatoire 
elementen die verantwoordelijk zijn voor Hox gen expressie in CFU-F binnen de 
grenzen van de Hox clusters vallen. Ook laten wij zien dat reeds bekende 
embryonale enhancers in staat zijn om Hox gen expressie in CFU-F aan te zetten, 
maar zonder een locatie specifiek patroon. Gebaseerd op de resultaten uit Hoofdstuk 
2 en 3 veronderstellen wij dat MSC uit het beenmerg niet ontstaan uit dezelfde 
embryonale voorlopers waaruit het bot gevormd wordt, maar dat ze deze plaatsen 
later koloniseren vanuit een andere locatie.  
 
In Hoofdstuk 4 bespreken we een ander celtype waarin Hox eiwitten een balangrijke 
rol spelen in de groei en differentiatie; de hematopoietische cellen, of bloed cellen. 
Het is niet bekend welke enhancer elementen verantwoordelijk zijn voor Hox gen 
expressie in bloed cellen. Uit ons onderzoek is gebleken dat deze elementen niet in 
de directe omgeving van het humane HOXA cluster ligt, en dus  waarschijnlijk een 
flinke afstand verwijderd zijn van dit cluster. We beschrijven ook de ontwikkeling 
van een methode waarmee deze enhancer elementen mogelijk opgespoord kunnen 
worden. 
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veel plezier aan beleefd en vooral heel veel van geleerd. Ik heb ook veel geleerd van 
onze discussies en ben nog altijd onder indruk van de grote hoeveelheid algemene 
kennis en brede intresse die je bezit.  
Elwin, jouw gastvrijheid is fenomenaal en bleek al direct uit de spontaniteit 
waarmee jij mij jouw sleutel overhandigde zodat ik ook buiten de normale tijden het 
lab op kon sluipen. Zonder jouw hulp had hoofdstuk twee weleens niet bestaan 
kunnen hebben. De behulpzaamheid is ook sprekend voor de hele afdeling 
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want jullie waren een aangenaam gezelschap in de soms toch wat eenzame dissectie 
of PCR Hoxjes. Maar, gelukkig was er ook nog Robbert, ook jij was een leuk en 
informatief dissectie gezelschap. 
Gert je hebt misschien geen idee wat voor een belangrijke rol je gespeeld hebt. Jouw 
grenzeloze geduld en luisterend oor als ik tegen je aan liep te klagen of gewoon 
zinloos liep te leuteren is bewonderenswaardig. Ik heb erg veel aan je gehad en van 
je geleerd. Ik was dan ook ontzettend blij dat we ook na de verhuizing hetzelfde lab 
bleven delen. Wie weet kom ik je de komende jaren nog af en toe tegen op de 
wormmeetings. Hannes, Jan, Renate en Suzanne: van flauwe grapjes, uiteenlopende 
muziekkeuzes tot discussies over de meest uiteeenlopende onderwerpen, ik had het 
niet willen missen.  
Een lab waar ik graag in rondhing danwel voor de gezelligheid danwel omdat er 
zoveel handige kennis te scoren was, is bij Ton, Rick en Sylvia. Jullie waren een 
soort rots in de branding (meubilair klinkt toch niet zo aardig) bij een steeds 
wisselende bezetting van de afdeling, zij het dat ook Ton met de tijd het honk 
verlaten heeft. Zo makkelijk ontkom je echter niet aan mijn boekje dus ik ga 
persoonlijke de grote klim maken. Sylvia, mocht je ooit nog een poging willen doen 
met de aaltjes, dan kun je rustig op visite komen, alhoewel door je tuin sluipen met 
een zaklantaarn natuurlijk ook wel gewoon een spannende hobby kan zijn. Rick, ik 
ben blij dat jij mijn paranimph wil zijn al was je wel een beetje een veeleisende 
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buurman. Je mag de katten altijd langs komen brengen als er geen oppas te vinden 
is.  
Elaine, bedankt voor je hulp en suggesties. Ik vind het fijn dat je in mijn commissie 
zit. Ook alle mensen op het lab en met name Esther en Karin bedankt voor jullie 
hulp en gezelligheid. Esther, ik heb er alle vertrouwen in dat je het enorm naar je zin 
gaat krijgen. Marion, jouw eeuwige opgewektheid en optimisme zijn een verrijking 
van de wereld. Zelfs als de dag enorm mislukt lijkt is een 5 minuten kletsmomentje 
met jou genoeg om in te zien dat het eigenlijk allemaal zo slecht nog niet is, bedankt 
daarvoor. Wendy, met jou in de buurt is het altijd leuk. Bedankt voor de gezellige 
avonden en veel plezier in Gent. Blijf zoals je bent en laat je niet te veel sturen door 
wat anderen van je zouden willen. Jeffrey, succes met de laatste loodjes. Je toekomst 
wordt vast en zeker succesvol.  Denk erom dat je bij je sollicitaties ook altijd even 
de kantine uitprobeerd voordat je ja zegt, een ondervoeding kun je je natuurlijk niet 
riskeren. En Katha, de volgende dim sum wordt in Basel, dan kun je meteen de 
gezinsuitbreiding komen knuffelen. 
Een van de leukste dingen die ik heb gedaan als AIO zijnde is het organiseren van 
de AIO meeting in Leuven. Ik heb daar veel plezier in gehad. Karin D met jou 
samenwerken hierin vond ik uitermate geslaagd. Je efficientie en doortastendheid 
met het regelen van dingen kunnen zeker als voorbeeld dienen. Je fruittaart dessert 
was ook geweldig. Dan nog natuurlijk de leden van onze enige eigen Pizza 
literatuur: Robbert-Jan, Steven, Marja, Gideon en ook de natuurlijk de wisselende 
spontane voorbijgangers, het was leuk en (soms) leerzaam.  
Jaqueline, bedankt voor je nuttige adviezen en suggesties tijdens de verschillende 
meetings, ik ben blij dat je in mijn commissie zit. Ook natuurlijk Sjaak en Riccardo, 
bedankt voor jullie inzet, ik waardeer het heel erg.  
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meer mensen zijn dan dat er ruimte is: Anna voor je geruststellende motiverende 
woorden en Petros (so many years and still no Austin Powers), Frank S, Daniël, 
Farzin, Eva, en met jullie vele anderen: Bedankt voor de leuke tijd. Er is eigenlijk 
geen lab waar ik niet iemand zou willen noemen en ik besluit dan maar met een zeer 
groot DANK JE WEL voor iedereen die hier niet genoemd is maar wel herinnerd zal 
worden.  Dan rest mij nog wat speciale mensen buiten het lab. 
Marianne, ik weet dat je er zelf ook veel plezier aan hebt gehad, maar zonder jou 
zou Sizzle er toch vaker bij ingeschoten zijn. Ik ken maar weinig mensen waar ik zo 
blindelings op durf te vertrouwen. Ook is mijn dank groot aan de familie van Zwol. 
Door jullie goede zorg heb ik mijn grootste bezit veilig kunnen achterlaten en is het 
zelfs vermenigvuldigd. Ik weet niet hoe ik het had moeten doen zonder jullie. Ik zal 
echter blij zijn als alles achter de rug is en alle beestjes lekker dicht bij mij in de 
buurt zijn.  
Ook een groot bedankt aan mijn ouders, die ik vooral de laatste maanden toch wel 
erg misbruikt heb als veelvuldig logeeradres en ik waarbij zeker niet altijd even 
vrolijk en vriendelijk was.  
Martijn, je was niet alleen een grote hulp bij het tot stand komen van dit proefschrift. 
Het was een bijzonder moment toen ik mij realiseerde dat ondanks dat mijn leven al 
behoorlijk volmaakt leek te zijn, jij het toch nog een stuk leuker kon maken.   
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Afscheid betekent de geboorte van de herinnering. 
(uit het gedachtengoed van Salvador Dali) 
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